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Abstract 
Low-density lipoprotein (LDL) is a complex of lipids and protein, and 
transports cholesterol in blood. LDL constitutes a large amount of lipids, some of 
them will easily undergo oxidation. Oxidized LDL is one of the major problems 
leading to cardiovascular disease, such as stroke and atherosclerosis. A number of 
studies indicated that oxidized LDL but not native LDL can impair 
endothelium-dependent vasorelaxation, possibly through the reduction of NO 
production. This impairment usually occurs at the early stage of atherosclerosis. 
Oxidized LDL may deposit on the vascular surface, leading to the formation of 
plaques, which subsequently reduce the lumen of blood vessels and increase the 
chance of getting stroke. 
The objectives of the present study were (1) to identify the damaging effects 
and tHe target sites of oxidized LDL on endothelium-dependent relaxation in vitro; (2) 
to investigate the in vivo damaging effects of LDL oxidation by tail injection method; 
(3) to study the effects of individual components of oxidized LDL on 
endothelium-dependent relaxation; and (4) to investigate the effects of oxidized 
cholesterol on serum lipid profile, endothelium-dependent relaxation and 
atherosclerotic plaque formation in hamsters. 
The results showed that the inhibitory effect on endothelium-dependent 
relaxation was directly proportional to the dose and exposure time of oxidized LDL. 
a-Tocopherol could partially reduced the inhibitory effect. The results obtained in the 
present study supported the proposed mechanism that oxidized LDL inactivated the 
II 
NO produced by eNOS. The present study also found that tail injection of native LDL 
significantly increased the circulating oxidized LDL in rats. The injected LDL also 
produced a hypercholestrolemic effect on rats and impaired the 
endothelium-dependent relaxation. 
LDL oxidation significantly increased the amount of lysophosphatidylcholine 
(LPC) and cholesterol oxidation products (COPs) and decreased the amount of 
unsaturated fatty acids and cholesterol in oxidized LDL. Among the oxidation 
products of oxidized LDL, LPC, COPs at 7-position (e.g. 7a-hydroxycholesterol, 
7P-hydroxycholesterol and 7-ketocholesterol) and oxidized linoleic acid caused a 
small but significant inhibition on endothelium-dependent relaxation, suggesting that 
no single component could mimic the effects caused by oxidized LDL, the 
components of oxidized LDL may act synergistically. 
Dietary cholesterol and oxidized cholesterol are the contributing factors for the 
formation of oxidized LDL. By using the hamsters as an animal model, it was found 
that both non-oxidized cholesterol and oxidized cholesterol at level of 0.1% 
significantly increased serum TG, TC and non-high density lipoprotein (non-HDL) to 
HDL ratio, with oxidized cholesterol being more potent than non-oxidized cholesterol. 
Oxidized cholesterol was more effective in increasing the aortic cholesterol level, 
atherosclerotic plaque area and inhibiting the endothelium-dependent relaxation than 
non-oxidized cholesterol, suggesting that dietary oxidized cholesterol be a more 
potent risk factor leading to cardiovascular disease than non-oxidized cholesterol. 
The present study provided strong evidence that the inhibitory effects of 
oxidized LDL on function of artery was due to its ability to reduce NO availability in 
III 
endothelium-dependent relaxation. However, no single component in oxidized LDL 
was responsible for this inhibitory effect and strong antioxidant could not prevent and 
reverse the inhibitory effect completely. Also, it was found that COPs in oxidized 
LDL was not the major cause of its bad effect, but instead that dietary oxidized 
cholesterol was a risk factor leading to cardiovascular diseases. Therefore, further 
investigations in humans are required to determine whether dietary oxidized 
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1.1 Introduction of low-density lipoprotein 
1.1.1 What are lipids? 
Lipids are a chemically diverse group of compounds, the common and defining 
feature of which is their insolubility in water. The biological functions of the lipids are 
equally diverse. Fats and oil are the principal stored forms of energy in many 
organisms, and phospholipids and sterols make up about half of the mass of biological 
membranes (Lehninger et al., 1993). 
1.1.2 Function and structure of cholesterol 
Cholesterol belongs to the group sterol in lipid family. It is a significant 
component of many organisms, especially mammals. Figure 1.1 shows the structure � 
of cholesterol. Cholesterol is the essential precursor for bile acids, corticoids, sex 
hormones and vitamin-D derived hormones (Gurr et al., 2002). 
1.1.3 Function and classification of lipoprotein 
Cholesterol and cholesteryl esters, triacylglycerols and phospholipids, are 
essentially insoluble in water. These lipids must, however, be moved from the tissue 
of origin, such as liver or intestine, to the tissue in which they will be stored or 
utilized. They are carried in the blood plasma from one tissue to another as plasma 
lipoproteins, macromolecular complexes of specific carrier proteins called 
apolipoproteins with various combinations of phospholipids, cholesterol, cholesteryl 
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esters and triglycerides (Lehninger et al； 1993). 
Lipoproteins are categorized into fives types according to size and density, that 
include chylomicrons, very low-density lipoproteins (VLDL), intermediate density 
lipoproteins (IDL), low-density lipoprotein (LDL) and high-density lipoprotein 
(HDL). (Simon et al., 2002) Table 1.1 shows the size and density of different 
lipoproteins. 
1.2 Functions of low-density lipoprotein 
Low-density lipoprotein (LDL) is a kind of lipoproteins with density between 
1.019- 1.063 g/mL. It is very rich in cholesterol and cholesteryl esters with apoB-100 
being as the major apoprotein. LDL carries cholesterol to peripheral tissues (in 
addition to the Liver) that have specific receptors that recognize apoB-100 (Lehninger 
et al., 1993). LDL particles are the major carrier of plasma cholesterol in humans. It 
transports about 75% of the blood's cholesterol to the body's cells (Simon et al., 




Basic structure of cholesterol 
Table 1.1 
Composition and characteristics of human plasma lipoprotein 
� Chylomicrons VLDL LDL HDL 
Protein (% mass) 2 1 20 50 
Triglycerides (% mass) 83 50 10 8 
Cholesterol (% mass) 8 22 48 20 
Particle mass (MDaltons) 0.4-30 10- 100 2-3.5 1.75-3.6 
Density range (gml-i) <0.95 0.95-1.006 1.019-1.063 1.063-1.210 
Diameter (nm) 80-1000 30-90 18-22 5-12 
Apolipoproteins AI, All, AIV，B-48， B-lOO，CI, B-lOO AI, All, AIV，CI, 
CI, cii, cm, E cii, cm, e cii, cm, d, e 
(Adapted from Gurr et al” 2002) 
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1.3 Basic structure of low-density lipoprotein 
Low-density lipoprotein is a kind of lipoprotein with density ranging from 
1.019 - 1.063 g/ml. Its diameter is between 18-25 nm. The mass of LDL particle is 
about 2 - 3.5 X 10^ Daltons. It consists of 22% of phospholipids, 48% cholesterol and 
cholesteryl ester, 20% of protein and 10% of triacylglycerols. The major type of 
apolipoprotein present on LDL is ApoB-100. LDL is protected from oxidative and 
free radical attacks by the presence of small quantities of anti-oxidants, such as 
ubiquinol and a—tocopherol (Hemming et al., 1996). Figure 1.2 shows the basic 
structure of LDL molecule. 
1.4 Principle on isolation and purification of low-density lipoprotein 
The standard procedures for separation of lipoprotein classes from each other 
are based on the density gradient centrifugation taking advantage of their differences 
in density. It is usual for the plasma to be derived from fresh blood in the presence of 
EDTA (Img/ml) to avoid coagulation and also to chelate heavy metal ions which 
otherwise increase autoxidation of phospholipids fatty acids as well as inhibiting 
phospholipases that may attack phospholipids. Addition of an anti-oxidant, e.g. 
vitamin E, may be a wise precaution. After removal of cells by centrifugation, the 
plasma may be subjected to density gradient ultracentrifligation in a swing-out rotor 
using stepwise gradient of densities of potassium bromide solution over the range 
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Figure 1.2 
Structure of a low-density lipoprotein (LDL) molecule. (Adapted from 
Lehninger et al., 1993) 
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Figure 1.3 
Schematic representation of density gradient ultracentrifugation of human 
plasma. The arrangement of sample in KBr solution and stepwise density 
gradient of KBr above it in the centrifugation tube of a swing-out rotor is 
indicated. (Adpated from Hemming et al” 1996.) 
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1.5 Cholesterol transport system 
1.5.1 Exogenous pathway of cholesterol metabolism 
The first pathway of cholesterol metabolism is the exogenous pathway, which is 
responsible for transport of dietary fat. After the dietary fat pass through the 
enterocytes, chylomicron particles are secreted and enter the plasma. The chylomicron 
is then interacts with other particles and acquire apolipoprotein, such as CII, CIII and 
apo E. The chylomicrons come into contact with the enzyme lipoprotein lipase and 
release fat into adipose tissue, skeletal and cardiac muscle and mammary gland. The 
triacylglyerol-depleted chylomicron particles become shrinking. The surface 
components dissociate and are acquired by other lipoprotein, particularly HDL. The 
half-life of chylomicron -triacylglycerol in the circulation is about 5 mins (Bengt et al., 
1998). 
1.5.2 Endogenous pathway of cholesterol metabolism 
The second pathway is the endogenous pathway. It involves the secretion of 
VLDL from the liver. In this pathway, VLDL particles also interact with lipoprotein 
lipase in capillaries and their core triacylglycerol is hydrolyzed. The half-life of 
VLDL particles in the circulation is about 12 hours. As the VLDL particles lose their 
triacylglycerol through successive interaction with lipoprotein lipase, they also lose 
their surface apolipoproteins，such as apo E and apo C, until they become LDL 
particles. But some of the VLDL particles are removed intact by endothelial VLDL 
receptors. LDL has longer half-life of about 2-2.5 days. LDL particles are removed by 
LDL-receptors on cell surface in the sub-endothelial space. The expression of 
LDL-receptor is closely regulated to maintain cellular cholesterol homeostasis. Thus, 
7 
the endogenous pathway is a mean of delivering fatty acids to tissue via lipoprotein 
lipase and perhaps the VLDL-receptor, and cholesterol via the LDL-receptor (Robert 
etal, 1998). (Figure 1.4) 
1.5.3 Reverse transport of Cholesterol 
The third pathway is HDL metabolism pathway. HDL pathway represents 
‘reverse cholesterol transport' or movement of cholesterol out of tissues and transport 
to the liver for ultimate excretion in the bile. In this pathway, the immature 
lipid-deficient HDL particles interact with cell membranes to acquire unesterified 
cholesterol from peripheral body cells. The unesterified cholesterol then becomes 
esterified with a long-chain fatty acid through the action of enzyme 
lecithin-cholesterol acyltransferase (L-CAT)，which is associated with HDL particles. 
The hydrophobic cholesteryl ester then moves to the core of the particle. HDL then 
circulates to the liver for excretion of cholesterol in bile (O'Connell et al., 2001). The 
three pathways together generate the systemic cycle of cholesterol metabolism in our 
body. 
1.6 Oxidation of LDL 
It is widely discussed that LDL oxidation is one of the major factors leading to 
cardiovascular diseases. Increased LDL oxidation will increase risk of cardiovascular 
disease. Therefore, the value of circulating oxidized LDL can be used to predict the 
cardiovascular risk (Mertens et al., 2001). 
8 
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Figui^ e 1.4 
Overview of the exogenous and endogenous pathways of lipoprotein 
metabolism. Lipolysis of particles by lipoprotein lipase (LPL) in capillaries of 
extra-hepatic tissues is simplified in this diagram. (Adapted from Gurr et ai, 
2002) 
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1.6.1 Agents that causes oxidation 
In vivo, LDL can be oxidized by lipoxgenases, myeloperoxidase, reactive 
nitrogen species (Mertens et al” 2001) and reactive oxygen species (Alexander et al., 
2002)(Figure 1.5). 
1.6.1.1 Lipoxygenases 
15-lipoxygenase, produced by endothelial cells and monocytes or macrophages, 
converts polyunsaturated fatty acids into lipid hydroperoxides and thereby oxidizes 
LDL. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early 
atherosclerosis in LDL receptor-deficient mice (Harats et al., 2000). 
1.6.1.2 Myeloperoxidase 
Activated phagocytes secrete myeloperoxidase that generates reactive species 
including hypochlorous acid (HOCl)，chloramines, tyrosyl radicals and nitrogen 
dioxide (NOi). These reactive species oxidize antioxidants, lipids and protein of LDL 
(Carr et al., 2000). Reactive nitrogen species generated by the 
myeloperoxidase-HiOiNOi system of monocytes convert LDL into an atherogenic 
form that is avidly taken up and degraded by macrophage, leading to foam cell 
formation (Podrez et al； 1999). 
1.6.1.3 Reactive nitrogen species 
Nitric oxide (NO) is a free radical released by various vascular cells (Guo et 
al. 1996). It inhibits copper-mediated oxidation (Rikitake et al., 1998) as well as 
cell-mediated oxidation of LDL (Malo-Ranta et aL, 1994)�NO is converted under 
10 
aerobic condition to nitrite, and low concentration of nitrite (12 |xM compared with 
physiological concentration up to 200 |LIM) inhibit myeloperoxidase-mediated 
oxidation of LDL (Carr et al., 2001). NO can act as an antioxidant by scavenging 
peroxyl radical. However, NO radical interacts with superoxide anion to form the 
peroxynitrite anion (ONOO ) that decomposes into hydroxyl radical OH •，which 
oxidizes LDL (Patel et al” 2000). 
1,6,1.4 Reactive oxygen species 
One of the important mechanisms that cause the oxidation of LDL is by the 
excessive production of reactive oxygen species (ROS) and especially oxygen free 
radicals (O2") and hydroxyl radical (OH ). These ROS are generated by oxidases 
coupled to hormone and cytokine receptors as well as to receptors for advanced 
glycation end products in diabetes (Alexander et al； 2002). These reactive oxygen 
species attack polyunsaturated fatty acids and proteins of LDL, initiating chain 
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Figure 1.5 
Schematic-diagram showing both in vitro (metal ions) and in vivo 
(lipoxygenase, myeloperoxidase) oxidation of LDL. After oxidation, oxidized 
LDL interacts with scavenger receptors present on endothelial cells， 
macrophages, and smooth muscle cells. (Adapted from Mortens et al” 
2001) 
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1.6.2 Factors that affect the susceptibility of LDL oxidation 
Previous studies have suggested that People with hyperlipidemia, type 2 
diabetes and smoking habit significantly increase the level of circulating oxidized 
LDL and the incidence of cardiovascular disease (Toshima et al., 2000; Holvoet et al., 
2001). The reason behind is still under investigation, but it is believed to be due to 
small dense LDL which will be more easily undergoes oxidation. 
1.7 Hyperlipidaemia 一 chance to increase LDL oxidation 
1.7.1 Definition of hyperlipidemia and hypercholesterolemia 
Hyperlipidemia is people with abnormal lipid level. Fasting total triglycerides 
level greater than 200 mg/dL or LDL cholesterol level greater than 130 mg/dL is in 
the condition of hyperlipidemia (Whitney et. al, 1999). 
1.7.2 Risk factors of hyperlipidaemia 
1.7,2.1 High fat low fibre diets: 
The Healthy Living Survey in 1999 examined the pattern of consumption of 
fresh vegetable, fresh fruit, milk, meat and high fat food in Hong Kong. It found that 
about a quarter of respondents ate fresh fruit less than once a day, and about one-tenth 
of respondents ate vegetables less than once a day. Women had a higher rate of 
consumption of both fresh vegetables and fresh fruit than men. Approximately 5% of 
the respondents ate food with high fat content everyday, while 17% said that they ate 
all visible fat in foods. One in six respondents drank milk once or more a day. Over 
two-thirds ate meat once or more a day (Department of health, Hong Kong). 
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L 7,2,2 Obesity 
In many epidemiological studies, obesity does not appear to be strongly 
associated with overall cholesterol levels, among obese individuals triglyceride levels 
are usually high while HDL levels tends to be low, both are the risk factors for heart 
disease. Obesity, in any case, has other effect, such as hypertension, that poses major 
risk to the heart (Marsh et al., 2003; Gurr et al., 2002). 
i . 7.2.3 Type II diabetes 
Both types of diabetes are the risk factor of heart disease. However, type II 
diabetes is more related to hyperlipidaemia (Simon et al., 2002). It is a more common 
form of diabetes, accounting for most diabetes cases. In type II diabetic patients, 
insulin resistance can be matched by increasing insulin secretion from the pancreas, 
which will increase circulating concentrations of non-esterified fatty acids (Marsh et 
al., 2003; Krentz et al., 2003). 
1 
L7.2,4 Genetic factors (Familial hyperlipidemias) 
Genetics play a major role in determining a person's blood cholesterol levels, 
people from families with a history of premature heart disease will have greater 
chance of abnormal triglycerides and cholesterol levels (Simon et al 2002). Genes 
may influence whether one has low HDL level, high LDL, triglycerides levels. People 
with hyperlipidemia that arised directly from genetic cause is known as primary 
hyperlipidemia. The three conditions described above are known as secondary 
hyperlipidemia (Gurr et al., 2002). 
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1.8 Diseases related to oxidized LDL 
1.8.1 Cardiovascular diseases 
1.8.1.1 Atherosclerosis and ischemic heart attack 
Coronary artery disease, commonly known as heart disease, is one of the major 
causes of death in Hong Kong and was responsible for about 5,600 deaths in 2002 
(Department of Health, Hong Kong). Many of these deaths were attributed to 
unhealthy cholesterol and lipid levels. Strong evidence points to LDL as the villain 
and HDL as a hero in the process. However the role of other lipids, notably 
triglycerides, is not entirely clear (Antonio et al., 1988). Unheathy cholesterol, 
particular low-density lipoprotein (LDL), forms a fatty substance called plaque, which 
builds up on the arterial walls. Smaller plaques remain soft, but older, larger plaques 
tend to develop fibrous caps with calcium deposits. (Van Meer et al., 1988). 
The long-term result is atherosclerosis, commonly called hardening of the 
arteries. Atherosclerosis involves the build-up of deposits in arterial walls, 
characterized by high concentration of lipids that derive from plasma lipoproteins. 
Calcification will be occurred in this process. Eventually the calcified and inelastic 
arteries become narrower (a condition known as stenosis) (Wang et al., 2003). As this 
process continues, blood flow slows and prevents sufficient oxygen-rich blood from 
reaching the heart. This condition leads to angina (chest pain) and, in severe cases to 
heart attack. On the other hands, smaller unstable plaques may rupture, triggering the 
formation of blood clots on their surface. The blood clots block the arteries and are 
important causes of heart attack (Pamham et al., 1988). 
Some factors may accelerate and enhance the process of atherosclerosis, such as 
high blood pressure, smoking, obesity, diabetes and sedentary lifestyle (Simon et al., 
2002). 
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1.8,1.2 Factors that affect incidence of atherosclerosis 
Two factors, the amount of triglyceride in lipoproteins and the size of LDL, 
which can affect the incidence of cardiovascular disease. 
1.8.1.2.1 Triglyceride-rich lipoprotein 
A population-based study found that an increase in plasma triglyceride of 1 
mmol/L, was associated with an increased risk of coronary artery disease of 14% and 
37% in men and women respectively (Hokanson et. la., 1996). The physician's Health 
Study found that the relative risk of myocardial infarction increased with increasing 
postprandial triglyceride concentration (Stampfer et al., 1996). The 
triglyceride/HDL-C ratio is widely used as an index of risk of cardiovascular disease. 
In an 8-year prospective study (Jeppensen et al., 1998), a 20% increase in this ratio 
predicted a significant 23% increase in the risk of cardiovascular disease. 
1.8.1.2.2 Small and dense LDL 
Previous studies demonstrated that reduced LDL peak particle size would 
increase the risk of cardiovascular disease (Lamarche et al., 2001; St-Pierre et al., 
2001; Gardner et al,, 1996). It is probably through the reduced LDL receptor affinity 
(Campos et al” 1996), slower plasma clearance, increased transport to subendothelial 
space (BJomheden et al., 1996)，increased binding to heparin sulfate proteoglycans in 
the arterial wall, and increased susceptibility to oxidation (Cahit et.al., 1993). 
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1,8.1.3 Stroke 
Stroke is an event in which blood flow to a part of the brain is cut off, also 
called cerebrovascular accident (CVA). Stroke is a consequence cause by 
atherosclerosis. As mentioned in 1.7.1, the plaque formed by oxidized LDL on the 
arterial wall ruptures after a certain degree of accumulation, these ruptured plaques 
trigger blood clots formation, which may prevent the blood flow. Restricted blood 
flow in the arteries feeding the brain may damage part of the brain tissue, causing 
stroke. Furthermore, the blockage of the arteries may increase the blood pressure. This 
higher blood pressure further damages the arterial wall and clots will formed at the 
area affected (Whitney et al., 1999). 
1.8.2 Common ways to reduce plasma cholesterol level 
1.8.2.1 Diet control 
Diet control is one of the common ways to reduce cholesterol intake. The aim of 
die control is to reduce fat, especially saturated fat, as well as the total energy intake. 
There is a two-step planning on reducing cholesterol level. The first step is to 
maintain total fat intake less than 30 percent of the daily energy intake, with saturated 
fatty acids less than 10% of the daily energy intake. Also cholesterol intake should 
less than 300mg a day. The second step is to maintain total fat intake less than 30 
percent of daily energy intake with saturated fat less than 7 %. Also dietary 
cholesterol intake should be less than 200mg a day. On the other hand, alcohol 
consumption should be avoided (Whitney et al； 1999). 
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1.8.2.2 Physical activity 
Physical activity is one of the efficient ways to reduce the body's cholesterol 
level and risk of cardiovascular disease. Weight training can raise HDL if undertaken 
regularly, but frequent and sustained aerobic activity may help to reduce LDL and 
increase HDL level. Since physical activity can modified the cholesterol profile, 
experts believed that physical activity should be the primary focus of cardiovascular 
disease prevention efforts (Whitney et. al, 1999). 
1.8.2.3 Drug therapy 
There are many cholesterol-lowering drugs, such as statins and Ezetimibe. 
Statins includes lovastatin (Davison et al” 2003), atorvastatin, fluvastatin and 
simvastatin (Bays et. al, 2003). Ezetimibe is a new drug to lower the cholesterol. Its 




Impairment of oxidized LDL on endothelium-
dependent relaxation 
2.1 Introduction 
It is known that there is a relationship between cardiovascular risk factors and 
endothelial dysfunction. Since the pioneering work of Furchgott and Zawadzki, 
(1980)，endothelium has been recognized as a major regulator of vascular homeostasis. 
Besides, endothelial dysfunction is also associated with hypertension, 
hypercholesterolemia, diabetes mellitus and estrogen deficiency (Vogel et al., 1997). 
It appears that oxidation of low density lipoprotein (LDL) is a major determinant of 
endothelial dysfunction, especially in hypercholesterolemia. 
Recent findings indicate that people with hyperlipidemia will increase the risk 
of LDL oxidation. Oxidized LDL is therefore taken up by macrophage (Fogelman et 
al., 19810). The macrophage develops into form cell and then undergoes adhesion and 
infiltration into the arterial wall, which contributes to the formation of fatty streak 
(Brown et al” 1986; Cominacini et al., 1997). Oxidized LDL stimulates the 
endothelium to secrete monocyte chemotactic protein 1，which induces the infiltration 
of monocyte into the subendothelial space. The oxidized LDL will also induce the 
smooth muscle cell migration by increasing the expression of platelet-derived growth 
factor. The oxidation product of phosphotidylcholine or cholesterol can cause the 
apoptosis of endothelial and smooth muscle cells (Heermeier et al., 2001). The 
accumulation of foam cells in endothelium and migration in smooth muscle cell 
promote the intimal thickening, resulting in reducing the size of arterial lumen. 
Damages of endothelial cells and reduction of arterial luminal size are the factors 
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contribute to the atherogenesis. Endothelial dysfunction is associated with enhanced 
platelet adhesion, increased procoagulant activity, and impaired fibrinolysis. Oxidized 
LDL stimulates platelet adhesion and aggregation by decreasing endothelial 
production of NO, increasing prostacyclin (PGI2) production, and stimulating the 
synthesis of prostaglandins and prostaglandin precursors. Oxidized LDL enhances the 
procoagulant activity of endothelium, which may easily lead to thrombosis and finally 
atherosclerosis (Ann et al, 2001). 
Another possible mechanism is that oxidized LDL activates Gi protein-coupled 
scavenger receptors, which will in turns deactivate L-arginine pathway. The presence 
of oxidized LDL will reduce the activity of NO Synthase (Figure 2.1) (Shimokawa et 
al 1989; Tanner et al, 1991). 
20 
5"HT oxLDL native Bk oxLDL S-HT TXA,> 
〒 I I i Scavenger 1 ” + Scavaicja' 
X receptor / W „ \ — r.'‘坤。�；一.� 
VV NOS + l~Arg f , _ _ — — J J l L 
• X I :N0 I EDHF r i i 
i • f 
5 Relaxation rxift!ucti-"»n 
, 
—'-^;；-^：：：^ 一 —““ 
Figure 2.1 
\ 
Endothelial dysfunction in hyperlipidemia and atherosclerosis. The major 
contrtibutor is oxidized low-density lipoprotein (OxLDL), which by activating 
scavenger receptors, impairs the activity of the L-arginine-NO pathway. The 
mechanism may involve inactivation of Gi protein (Gj), decrease intracellular 
availability of L-arginine (L-Arg), and increased breakdown of NO by 
superoxide (CV). Oxidized LDL further activates endothelin (ET) gene 
expression and production via protein kinase (PKC). (Adapted from Tanner et 
al., 199,1) 
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2.1.1 Properties and function of phenylephrine hydrochloride 
Phenylephrine hydrochloride is an a 1-adrenergic agonist used as a mydriatic, 
nasal decongestant, and cardiotonic agent. It is a typical contracting agent used to 
study endothelium-dependent relaxation (Thomas et al” 1990). 
2.1.2 Properties and function of acetylcholine 
Acetylcholine is a kind of neurotransmitter. In vertebrates, acetylcholine is the 
major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic 
effector junctions, a subset of sympathetic effector junctions, and at many sites in the 
central nervous system. It is generally not used as an administered drug because it is 
broken down very rapidly by cholinesterases, but it is useful in some 
ophthalmological applications. In endothelium, acetylcholine stimulates Mi and 
Mi-muscarinic receptors, which involve in the release of two factors, EDHF and 
EDRF. Acetylcholine is produced by the enzyme cholineacetyltransferase in 
endothelial cells. Acetylcholine produces a sustained endothelium-dependent 
relaxation through the activation of NO production, which activates guanylate cyclase 
(Thomas et al., 1990). 
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2.2 Objectives 
The objectives of the present study were to examine the effect of time, dose 
and co-incubation of native LDL and copper(II) sulphate on acetylcholine-induced 
endothelium-dependent relaxation, the effect of a -tocopherol pretreatment on 
oxidized LDL-treated endothelium-dependent relaxation and to identify the target 
sites of oxidized LDL. 
I 
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2.3 Materials and methods 
2.3.1 Preparation of drugs 
Phenylephrine hydrochloride, acetylcholine hydrochloride, isoprenaline, 
nifedipine, forskolin and L-arginine were purchased from Torcis (Ballwin, MO). 
Copper(II) sulphate, sodium nitropmsside (SNP)，thapsigargin were purchased from 
Sigma Co, (Chicago, USA), a -Tocopherol was purchased from ICN Biomedicals, 
Inc, (Costa Mesa, USA), a -Tocopherol was dissolved in dimethyl sulfoxide (DMSO)， 
others were dissolved in nano pure water. DMSO at 0.2% did not affect the sustained 
contraction induced by phenylephrine. 
Thapsigargin is a potent inhibitor of Sarco-endoplasmic reticulum (SR) 
Ca^^-ATPase, which can deplete the intracellular Ca2+ storage. Since intracellular Ca^ "^  
2+ 
stores play an essential role in the regulation of the cytoplasmic free Ca 
concentration by mobilization and refilling of stored Ca，emptying of intracellular 
Ca2+ stores results in the activation of store-operated entry channels mediating influx 
I 
of extracellular Ca^ "^ , which activates endothelial nitric oxide synthase (eNOS). 
Sodium nitropmsside is a kind of endothelium-independent vasodilator, 
which acts as nitric oxide donor. SNP requires either irradiation with light or 
one-electron reduction to release NO. SNP is clinically used to reduce blood pressure, 
such as in hypertensive emergencies. 
Isoprenaline, also named as isoproterenol, is an isopropyl analog of 
epinephrine, which acts almost exclusively on beta-adrenergic receptor. It is used 
mainly as bronchodilator and heart stimulant. 
Nifedipine is a potent vasodilator agent with calcium antagonistic action 
(calcium channel blocker). It is a useful anti-anginal agent that also lowers blood 
pressure. 
Forskolin is a potent activator of the adenylate cyclase system and the 
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biosynthesis of cyclic AMP. It is extracted from the plant Coleus forskohlii. It has 
antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth 
muscle relaxant activities. It also lowers intraocular pressure and promotes release of 
hormones from the pituitary gland. 
L-arginine is an essential amino acid, which is a major component of proteins. 
L-arginine is the substrate of endothelial nitric oxide synthase. It acts as NO donor in 
the endothelium-dependent relaxation. It is a commonly used drug for treatment of 
hypertension. 
Figure 2.2 shows a simplified diagram on endothelium-dependent relaxation 
and the target sites of different chemical agents used in this study. 
2.3.2 Preparation of human native LDL 
Fresh plasma from healthy subjects was obtained from the Hong Kong Red 
Cross (15 King's Park Road, Kowloon, Hong Kong). LDL was isolated from plasma 
1 
according to the method previously described with some modification (Zhang et al., 
1997). To minimize the oxidation of LDL, the centrifuge tubes containing plasma 
were flushed with nitrogen gas. In brief, the plasma was centrifuged at 3000 g for 5 
minutes at 4°C to remove cells and cell debris. NaCl-KBr solution (dissolve 153 g 
NaCl, 354 g KBr in one liter of water, density: 1.33 g/ml) was then added to increase 
the plasma density to 1.019 g/ml. The plasma was re-centrifliged at 160,000 g at 4°C 
for 24 hours. The top layer containing chylomicron and very low-density lipoprotein 
(VLDL) was removed. After that, the density of remaining plasma fractions was 
increased to 1.064 and re-centrifuged at 160,000 g for an additional 24 hours at 4°C. 
The top LDL fraction was collected and then flushed with nitrogen and stored at -70 
oc. The protein content of isolated LDL was determined using Lowry's method 
(Lowry et aL, 1951). 
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Figure 2.2 
Simplified diagram showing the endothelium-dependent relaxation and 
target sites of isoprenaline, thapsigargin, L-arginine, SNP, Nifedipine and 
Forskolin. 
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2.3.3 Preparation of oxidized LDL 
Oxidation of LDL was carried out as previously described with some 
modification (Puhl et al., 1994). In brief, freshly prepared native LDL was diluted to 5 
mg/ml with 0.01 M sodium phosphate buffer (pH 7.4). LDL (1 ml) was mixed with 
25|jL of 10 mM CUSO4 solution and incubated at 37°C up to 48 h. The oxidation was 
then stopped by addition of 0.1% EDTA and frozen at - 20°C. The oxidation state of 
LDL was determined by measuring the production of thiobarbituric acid-reactive 
substances (TEARS) as previously described (Buege et al., 1978). In brief, 2 ml of 
0.67% thiobarbituric acid and 15% trichloroacetic acid in O.IN HCl solution were 
added to the LDL. The incubation mixture was then heated at 95°C for 1 hour, cooled 
on ice, and centrifuged at 1500 g for 10 minutes. TEARS was determined by 
measuring the absorbance at 532 nm. Calibration was done with a malondialdehyde 
(MDA) standard solution prepared from tetramethoxylpropane. The value was 
expressed as nmol MDA/mg LDL protein. 
2.3.4 Preparation of aorta 
After approval from the Animal Ethical Committee of the Chinese University 
of Hong Kong was obtained, male Sprague-Dawley rats weighing 250 -280g were 
killed with pure carbon dioxide (purchased from Hong Kong Oxygen). The thoracic 
aorta was dissected out, and surrounding connective tissues and fat were removed 
under dissection microscope. Then, the aorta was cut into 3 mm long aortic ring 
segements and each segment was suspended between two stainless steel hooks in a 10 
ml organ bath chamber filled with normal Krebs-Henseleit solution (119 mM NaCl, 
4,7 mM KCl，2.5 mM CaCli, 1 mM MgCh, 25 mM NaHCOs, 1.5 mM KH2PO4, 11.1 
mM D-glucose). The chamber was bubbled with a mixture of 95% oxygen and 5 % 
carbon dioxide and kept at 37°C throughout the experiment. For the two stainless steel 
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hooks, one of them was mounted at the bottom of the bath while another one was 
connected to a Grass FT03 force-displacement transducers (Grass Instrument) and the 
isometric contraction was measured by transducer and recorded by MacLab computer 
system (Figure 2.3). One-gram basal tension was applied to all aortic rings and rings 
were allowed to equilibrate for 30 minutes. During this time, the bath solution was 
replaced with pre-warmed, oxygenated Krebs-Henseleit solution for 3 to 4 times. 
After equilibrate period, the rings were first contracted with 0.3|aM phenylephrine to 
test vessel's contractibility and then relaxed by 0.3|iM acetylcholine to assess 
integrity of the endothelial layer. Then, the rings were rinsed several times in 
pre-warmed and oxygenated Krebs-Henseleit solution until the baseal tension was 
restored and allowed to equilibrate for 60 mins. In endothelium-intact arteries, 0.3|aM 
acetylcholine can cause over 80% relaxation and rings were discarded if they fail to 
relax more than 80%. 
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The diagram shows the structure of organ bath chamber. Aortic ring was 
mounted into the two hooks of organ bath chamber supplied with gas and 
warm water circulation. The lower hook is fixed on the chamber while the 
upper hook was connected to a Grass FT03 force-displacement transducers 
(Grass Instrument) and the isometric contraction was measured by transducer 
and recorded by MacLab computer system. 
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2.3.5 Measurement of Isometric Force in vitro 
2.3.5.1 Protocol 1- Dose effect of oxidized LDL on acetylcholine-induced 
vasorelaxation 
After testing each ring's integrity of the endothelial layer, a plateau 
contraction was obtained after addition of l|iM phenylephrine to the bathing solution 
and then control concentration-dependent relaxation to acetylcholine was produced. 
They were then rinsed several times with pre-warmed Krebs-Henseleit solution until 
basal tension was restored and the second concentration-response curve to 
acetylcholine was produced again. To test the dose effect of oxidized LDL, rings were 
exposed to different concentration of oxidized LDL (0, 10, 30，50，100 |xg/ml) for 30 
min prior to the second concentration-dependent relaxation to acetylcholine. Freshly 
prepared native LDL was used in the negative control experiment. In which, rings 
were exposed to 100 |xg/ml native LDL for 30 min prior to the second 
concentration-dependent relaxation to acetylcholine. 
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2.3.5.2 Protocol 2 - Time effect of oxidized LDL on acetylcholine-induced 
vasorelaxation 
After integrity of the endothelial layer was tested, a plateau contraction was 
obtained after addition of l|xM phenylephrine to the bathing solution and then control 
concentration-dependent relaxation to acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve to acetylcholine was produced 
again. To test the time effects of oxidized LDL, rings were exposed to 100|ig/ml 
oxidized LDL for different time (30，60 and 120 min) prior to the second 
concentration-dependent relaxation to acetylcholine. Freshly prepared native LDL 
was used in the negative control experiment. In which, rings were exposed to 100 
30 
|ag/ml native LDL for 120 min prior to the second concentration-dependent relaxation 
to acetylcholine. 
2.3.5.3 Protocol 3 - Effect of co-incubation of LDL and copper(II) sulphate on 
acetylcholine-induced vasorelaxation 
After the rings was allowed to equilibrate in basal tension, a plateau 
contraction was obtained after addition of l[iM phenylephrine to the bathing solution 
and then control concentration-dependent relaxation to acetylcholine was produced. 
They were then rinsed several times with pre-warmed Krebs-Henseleit solution until 
basal tension was restored and the second concentration-response curve to 
acetylcholine was produced again. In order to test effect of degree of LDL oxidation, 
rings were exposed to 5|xM Copper(II) sulphate and 100|xg/ml freshly prepared native 
LDL for different time (0, 5, 10, 15, 30, 45，60, 90 and 120 min) prior to the second 
concentration-dependent relaxation to acetylcholine. Native LDL without addition of 
I 
Copper(II) sulphate was used in the negative control experiment. In which, rings were 
exposed to 100 |ig/ml native LDL for 120 min prior to the second 
concentration-dependent relaxation to acetylcholine. Before the addition of 
phenylephrine during the second concentration-dependent relaxation, 1 ml of bathing 
solution was removed and 50|j,l 0.1 % EDTA was added to prevent further oxidation. 
The bathing solution was then subjected to TEARS assay as described in part 2.3.3 of 
Chapter 2. The solution was kept on ice before the TEARS determination. 
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2.3.5.4 Protocol 4 - Effect of oxidized LDL on selected vasodilators 
After testing each ring's integrity of the endothelial layer, a plateau 
contraction was obtained after addition of l|iM phenylephrine to the bathing solution 
and then control concentration-dependent relaxation to either SNP, thapsigargin, 
isoprenaline, nifedipine or forskolin was produced. They were then rinsed several 
times with pre-warmed Krebs-Henseleit solution until basal tension was restored and 
the second concentration-response curve to acetylcholine was produced again. To test 
the dose effect of oxidized LDL, rings were exposed to 100 |ig/ml oxidized LDL for 
30 min prior to the second concentration-dependent relaxation to either SNP, 
thapsigargin, isoprenaline, nifedipine or forskolin. Freshly prepared native LDL was 
used in the negative control experiment. In which, rings were exposed to 100 jxg/tnl 
native LDL for 30 min prior to the second concentration-dependent relaxation to 
acetylcholine. 
2.3.5.5 Protocol 5 - Effect of pretreatment of L-arginine on oxidized LDL impaired 
-endothelium-induced relaxation. 
After 60 min equilibrium under basal tension, a plateau contraction was 
obtained after addition of l^iM phenylephrine to the bathing solution and then control 
concentration-dependent relaxation to acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve to acetylcholine was produced 
again. To examine the effect of L-arginine, rings were incubated with lOOjiM 
L-arginine for 90 min prior to the addition of oxidized LDL. L-arginine was used in 
the negative control experiment. In which, rings were exposed to 
100|J-M a -tocopherol prior to the second concentration-dependent relaxation to 
acetylcholine. 
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2.3.5.6 Protocol 6 - Effect of a-tocopherol on oxidized LDL-damaged acetylcholine-
induced vasorelaxation 
After 60 min equilibrium under basal tension, a plateau contraction was 
obtained after addition of l|aM phenylephrine to the bathing solution and then control 
concentration-dependent relaxation to acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve to acetylcholine was produced 
again. In order to test effect of oxidized LDL, rings were exposed to lOOng/ml 
oxidized LDL for 30 mins prior to the second concentration-dependent relaxation to 
acetylcholine. To examine the effect of a -tocopherol, rings were incubated with 
different concentration of a -tocopherol (20, 40 and 100|iM) for 90 min prior to the 
addition of oxidized LDL. a -tocopherol was used in the negative control experiment. 
In which, rings were exposed to different concentration of a -tocopherol (20，40 and 
lOOjxM) prior to the second concentration-dependent relaxation to acetylcholine. 
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2.3.5.7 Protocol 7 - Effect of a-tocopherol on LDL and copper(II) sulphate-induced 
endothelial dysfunction. 
After 60 min equilibrium under basal tension, a plateau contraction was 
obtained after addition of IjxM phenylephrine to the bathing solution and then control 
concentration-dependent relaxation to acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve to acetylcholine was produced 
again. In order to test whether the antioxidant effect of a -tocopherol can prevent the 
damages caused by the oxidized LDL produced by Copper(II) sulphate, rings were 
exposed to different concentration of a -tocopherol (20，40 and lOO^M) for 90 min 
and then lOO i^g/ml freshly prepared native LDL with 5|aM Copper(II) sulphate for 
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120 min prior to the second concentration-dependent relaxation to acetylcholine. 
Before the addition of phenylephrine during the second concentration-dependent 
relaxation, 1 ml of bathing solution was removed and 50|il 0.1 % EDTA was added 
to prevent further oxidation. The bathing solution was then subjected to TEARS assay 
as described in part 2.3.3 of Chapter 2. The solution was kept on ice before the 
TEARS determination. 
2.3.6 Western blot analysis of endothelial nitric oxide synthase (eNOS) protein 
eNOS protein content was evaluated with standard immunoblotting methods. 
Aortic rings were frozen in liquid nitrogen and subsequently homogenized with 
ice-cold RIPA lysis buffer containing 1 )ig/ml leupetin, 5 |Lig/ml aprotonin, 100 |ag/ml 
phenylmethylsulfonyl fluoride (PMSF), 1 mmol/L sodium orthovanadate, 1 mmol/L 
EGTA， 1 mmol/L EDTA, 1 mmol/L sodium fluoride, and 2 mg/ml 
3-glycerolphosphate. The lysates were sonicated on ice for 30 minutes and then 
I 
centrifuged at 20,000 g for 20 min at 4�C. The supernatant was collected and analyzed 
for measurement of the protein concentration using the Lowry method (Bio-Rad, 
Hercules, USA) according to manufacturer's instructions. One volume of 2x gel 
loading buffer containing 5% B-mercaptoethanol was added and the samples were 
denatured by boiling for 5 minutes. For each sample, 80 |Lig protein was separated 
under reducing conditions on a 7.5% SDS-polyacryamide gel. At the same time, 
prestained and biotinylated molecular weight markers, and positive control sample 
were run in parallel to all samples. The resolved proteins were electrophoretically 
transferred to an immobilon-P polyvinylidene difluoride (PVDF) membrane 
(Millipore, Billerica, USA) using a mini protein tank blot equipment (Bio-Rad, 
Hercules, USA) by 100 V for 60 min at 4 � C . The membranes were blocked with a 
5% non-fat milk (Nestle (Hong Kong) in phosphate buffer saline tween (PBST) for 60 
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min at room temperature and subsequently exposed to a polyclonal rabbit anti-eNOS 
antibody (1:500, Santa Cruz Biotechnology Inc., California, USA) overnight at 4 
The membranes were subsequently probed with a secondary anti-rabbit antibody 
conjugated to horseradish peroxidase (DakoCytomation, Glostrup, Denmark) at a 
dilution of 1:2500 for 1 hr at room temperature. The membranes were developed with 
an enhanced chemiluminescence detection system (ECL reagents; Amersham 
Pharmacia, Uppsala, Sweden) and then exposed on X-ray films (Fuji, Japan). 
Densitometry was performed using a documentation program (Fluorchem, Alpha 
Innotech Corp.). eNOS corresponding to a 145-kDa band was visualized by 
comparing to molecular weight markers. Additional verification of eNOS was 




Results were expressed as percentage relaxation of the agonist-constricted 
arterial rings. Data was presented as means 土 SD of n experiments. Statistical 
significance was analyzed by Student's t-test or by one way ANOVA followed by 
Newman-Keuls test when more than two treatments were compared. The difference 
was considered significant when p<0.05. 
2.4 Results 
2.4.1 Dose effect of oxidized LDL on acetylcholine-induced vasorelaxation 
In order to examine the effect of oxidized LDL on acetylcholine-induced 
relaxation, two consecutive concentration-response curves for acetylcholine were 
constructed. The first curve served as the control experiment. After the first 
concentration-response curves, rings were exposed to different concentration of 
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oxidized LDL (0，10，30，50, 100 |ag/ml) followed by second concentration-response 
curve and showed different degree of inhibition on relaxation in response to different 
concentration of oxidized LDL. The greater inhibition showed by a higher 
concentration of oxidized LDL (Figure 2.4A). The pD2 (-log IC50) values for 
aceylcholine-induced relaxation are presented in Figure 2.4B and the maximal 
relaxation (Emax %) induced by aceylcholine in Figure 2.4C. The contraction force 
elicited by phenylephrine (5.37 土 1.27 mN in control group (0|ig/ml oxidized LDL) 
and 10.57+1.07 mN in 100|ig/ml oxidized LDL treated group) was also measured, 
which showed an enhanced effect in contraction after oxidized LDL treatment (Figure 
2.4D). 
2.4.2 Time effect of oxidized LDL on acetylcholine-induced vasorelaxation 
After first control concentration-response curves, rings were exposed to 
100|xg/ml oxidized LDL for different times (30, 60 and 120 minutes) followed by 
I 
second concentration-response curve and showed different degree of inhibition on 
relaxation in response to different incubation time. The greater the inhibition showed 
by the longer incubation time of oxidized LDL (Figure 2.5A). The pD2 (-log IC50) 
values for aceylcholine-induced relaxation are presented in Figure 2.5B and the 
maximal relaxation (Emax %) induced by aceylcholine in Figure 2.5C. 
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Figure 2.4 
Concentration-response curves for 1[JM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Treatment of 
different concentration of oxidized LDL (Ox-LDL) on acetylcholine-induced 
concentration- depentdent relaxation. (B) The pD2 values (-log IC50) for 
acetylcholine. (C) The maximal relaxation (Emax %) induced by acetylcholine. 
(D) Average conctractile force of aortic rings induced by 1pM Phenylephrine in 
control (0 pg/ml oxidized LDL) and 100 pg/ml oxidized LDL treated groups. 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b, 
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Figure 2.5 
Concentration-response curves for 1pM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10fjM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
different incubation periods of oxidized LDL (Ox-LDL) on acetylcholine-induced 
concentration- depentdent relaxation. (B) The pD2 values (-log IC50) for 
acetylcholine. (C) The maximal relaxation (Emax %) induced by acetylcholine. 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b, 
c) differ significantly at P<0.05. 
38 
2.4.3 Effect of co-incubation of LDL and copper(II) sulphate on 
acetylcholine-induced vasorelaxation 
After first control concentration-response curves, rings were exposed to 
both native LDL and copper(II) sulphate for different time (5，10，15, 30, 60, 90, 120 
minutes) before the construction of the second concentration-response curve for 
acetylcholine. Results showed that rings subjected to longer incubation with both 
copper(II) sulphate and native LDL generally showed greater inhibition on relaxation 
(Figure 2.6A). The pD2 (-log IC50) values for aceylcholine-induced relaxation are 
presented in Figure 2.6B and the maximal relaxation (Emax %) induced by 
aceylcholine in Figure 2.6C. The bathing solution was tested against TEARS assay 
and expressed as percentage oxidation (TEARS value of bathing solution against 
TEARS value of 24 hours oxidized LDL) against different time of incubation. It was 
found that percentage oxidation of LDL is directly proportional to the incubation time 
of native LDL and copper(II) sulphate in the organ bath chamber (Figure 2.6D). 
I 
Incubation of rings with 5|iM Copper(II) sulphate alone did not affect the 
acetylcholine-induced relaxation (data not shown). 
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Figure 2.6 
Concentration-response curves for 1|JM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
co-incubation of native LDL and copper(ll) sulphate on acetylcholine-induced 
concentration-depentdent relaxation. (B) The pD2 values (-log IC50) for 
acetylcholine. (C) The maximal relaxation (Emax %) induced by acetylcholine. 
(D) Percentage of LDL oxidized in organ bath chamber against time as 
compared to 24h Copper-mediated oxidized LDL Values are expressed as 
means 土 SD (n=6). Means with different letters (a, b, c) differ significantly at 
P<0.05. 
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2.4.4 Effect of oxidized LDL on selected vasodilators 
Treatment of 100|xg/ml oxidized LDL significantly impaired SNP (Figure 2.7)， 
thapsigargin (Figure 2.8) and isoprenaline (Figure 2.9) -induced relaxation when 
compared to that of the control (P<0.05), while treatment of oxidized LDL did not 
affect both nifedipine (Figure 2.10) and forskolin (Figure 2.11) -induced relaxation 
when compared to that of the control. 
2.4.5 Effect of pretreatment of L-arginine on oxidized LDL impaired 
-acetylcholine-induced relaxation 
Pretreatment of L-arginine did not improved acetylcholine-induced relaxation 
after treatment with oxidized LDL at low concentration (3nM- 1 i^M) of acetylcholine, 
but it slightly and significantly improved the acetylcholine-induced at high 
concentration (l|iM - lOjxM) of acetylcholine when compared to that of control and 
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Figure 2.7 
(A) Concentration-response curves for 1|JM phenylephrine-induced contractile 
responses and SNP-induced concentration-dependent relaxation. (B) The pD2 
values (-log IC50) for SNP. (C) The maximal relaxation (Emax %) induced by 
SNP. Values are expressed as means + SD (n=6). Means with different letters 
• (a, b) differ significantly at P<0.05. 
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(A) Concentration-response curves for 1|JM phenylephrine-induced contractile 
responses and thapsigargin-induced concentration-dependent relaxation. (B) 
The maximal relaxation (Emax %) induced by thapsigargin. Values are 
expressed as means 土 SD (n=6). Means with different letters (a, b) differ 
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Figure 2.9 
(A) Concentration-response curves for IpM phenylephrine-induced contractile 
responses and isoprenaline-induced concentration-dependent relaxation. (B) 
The maximal relaxation (Emax %) induced by isoprenaline. Values are 
expressed as means 土 SD (n=6). Means with different letters (a, b) differ 
significantly at P<0.05. 
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Figure 2.10 
(A) Concentration-response curves for 1|JM phenylephrine-induced contractile 
responses and nifedipine-induced concentration-dependent relaxation. (B) 
The pD2 values (-log IC50) for nifedipine. (C) The maximal relaxation (Emax %) 
induced by nifedipine. Values are expressed as means 土 SD (n=6). 
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Figure 2.11 
(A) Concentration-response curves for IpM phenylephrine-induced contractile 
responses and forskolin-induced concentration-dependent relaxation. (B) The 
pD2 values (-log IC50) for forskolin. (C) The maximal relaxation (Emax %) 
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Figure 2,12 
(A) Concentration-response curves for 1|JM phenylephrine-induced contractile 
responses and acetylcholine-induced concentration -dependent relaxation 
after treatment of L-arginine. (B) The maximal relaxation (Emax %) induced by 
acetylcholine. Values are expressed as means 土 SD (n=6). Means with 
different letters (a, b, c) differ significantly at P<0.05. 
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2.4.6 Effect of a -tocopherol on oxidized LDL-damaged acetylcholine- induced 
vasorelaxation 
In order to determine whether a -tocopherol treatment could improve or 
normalize the endothelial function of aortic rings affected by oxidized LDL. After the 
first control curve was constructed, rings were exposed for 120 minutes to different 
concentration of a -tocopherol (20, 40 and 100 |xM) followed by 30 minutes exposure 
to oxidized LDL before the construction of second concentration-response curve for 
acetylcholine. Figure 2.13A shows that pre-treatment with a -tocopherol (20, 40 and 
100 |iM) significantly reduced the inhibitory effect of oxidized LDL, which partially 
improved the relaxation caused by acetylcholine. But increase in the concentration of 
a -tocopherol from 20i^M to 100|xM did not increase the improvement effect on the 
impaired acetylcholine-induced relaxation. The pD2 values obtained from analysis of 
concentration-response curves shown in Figure 2.13A are presented in Figure 2.13B. 
Prolonged exposure (up to 240 minutes) to a -tocopherol did not induce greater effect 
t 
as compared with 120 minutes incubation (Data not shown), a -Tocopherol up to 
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Figure 2.13 
Concentration-response curves for 1|JM phenylephrine hydrochloride- induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
a-tocopherol on acetylcholine-induced concentration-depentdent relaxation in 
the presence of oxidized LDL (Ox-LDL). (B) The pD2 values (-log IC50) for 
acetylcholine. (C) The maximal relaxation (Emax %) induced by acetylcholine. 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b， 
c) differ significantly at P<0.05. 
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2.4.7 Effect of a -tocopherol on LDL and copper(II) sulphate-induced 
endothelial dysfunction. 
In order to determine whether a -tocopherol treatment could improve or 
normalize the endothelial function of aortic rings affected by co-incubation of native 
LDL and copper(II) sulphate. After the first control curve was constructed, rings were 
exposed for 120 minutes to different concentration of a -tocopherol (20, 40 and 100 
|xM) followed by 30 minutes co-exposure to native LDL and copper(II) sulphate 
before the construction of second concentration-response curve for acetylcholine. 
Figure 2.14a shows that pre-treatment with a -tocopherol (20，40 and 100 |iM) 
significantly reduced the inhibitory effect of native LDL and copper(II) sulphate, 
which showed a greater improvement than that of oxidized LDL pretreated with 
a -tocopherol on acetylcholine-induced vasorelaxation. The pD2 values obtained 
from analysis of concentration-response curves shown in Figure 2.14A are presented 
in Figure 2.14B. Prolonged exposure (up to 240 minutes) to a -tocopherol did not 
induce greater effect as compared with 120 minutes incubation (Data not shown). 
2.4.8 eNOS Protein expression 
Western blot analysis in Figure 2.15 shows that treatment of native LDL, 
oxidized LDL and/or a -tocopherol did not affect the eNOS protein levels in 
endothelium-intact aortic rings when compared to the control. 
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Figure 2.14 
Concentration-response curves for 1[JM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 卿 M acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
a-tocopherol on acetylcholine-induced concentration-depentdent relaxation in 
the presence of native LDL and copper(ll) sulphate. (B) The pD2 values (-log 
IC50) for acetylcholine. (C) The maximal relaxation (Emax %) induced by 
acetylcholine. (D) Percentage of native LDL oxidized in organ bath chamber at 
the end of incubation as compared to 24h Copper-mediated oxidized LDL 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b， 
c) differ significantly at P<0.05. 
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Figure 2.15 
Effects of native LDL (n-LDL)，oxidized LDL (ox-LDL) and a-tocopherol 




Endothelium plays an important role in regulating the cardiovascular functions 
since it is located between the circulating blood and vascular smooth muscle. 
Presence of oxidized LDL is believed to be the early events in pathogenesis of 
endothelial dysfunction-associated cardiovascular diseases (Cai et. al, 2000; Guzik et 
al., 2000; Wamholtz et al., 1999). 
The present study demonstrated that oxidized LDL significantly attenuated 
acetylcholine-induced endothelial-dependent relaxation. It was found that the 
inhibitory effect was proportional to both incubation time and dose of oxidized LDL, 
longer incubation time and high dose of oxidized LDL caused greater inhibition on 
endothelium-dependent relaxation (Figure 2.4). It was also found that treatment of 
oxidized LDL increased contractile force of aortic rings (5.37 土 1.27 mN in control 
and 10.57±1.07 mN in 100|xg/ml oxidized LDL), it may be due to the activation of 
1 
protein kinase C or reduction in the production of NO (Shimokawa et al. 1989; Tanner 
et al., 1991). The present study was in agreement with that of Zhao et al. (1998) and 
Chan et al. (2003)，who also found that oxidized LDL significantly inhibited 
acetylcholine-induced relaxation and increased contractile responses to 
vasoconstrictor. 
. The present study showed that co-incubation of native LDL and copper(II) 
sulphate also caused significant inhibition on endothelium-dependent relaxation. As 
copper(II) sulphate mediated the oxidation of native LDL in the favorable condition 
of organ bath chamber (with both oxygen supplied and warm temperature), native 
LDL oxidized quickly to form oxidized LDL, that was supported by the results 
obtained in Figure 2.6D. As longer incubation period produced more oxidized LDL, 
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the inhibitory effect of co-incubation of native LDL and copper(II) sulphate was 
increased. The results suggested that there must be some kind of substances formed or 
released during LDL oxidation, which was responsible for the inhibitory effect of 
oxidized LDL. This is the first study to demonstrate the effects co-incubation of 
native LDL and copper(II) sulphate on acetylcholine-induced relaxation. 
The present study demonstrated that oxidized LDL significantly inhibited 
thapsigargin and isoprenaline -induced relaxation. However, oxidized LDL did not 
affect the nifedipine and forskolin -induced relaxation. Since both thapsigargin and 
isoprenaline, together with acetylcholine are endothelium-dependent vasodilators 
while nifedipine and forskolin are endothelium-independent vasodilators, it was 
concluded that the target sites of oxidized LDL must be located on somewhere in the 
endothelium. Furthermore, L-arginine treatment did not improve the relaxation at low 
concentration of acetylcholine, which meant oxidized LDL did not affect the 
I 
L-arginine supply to eNOS for production of NO. It was also found that oxidized LDL 
affected SNP-induced relaxation. SNP is a kind of endothelium-independent 
vasodilator, which could directly decompose into NO in the presence of light. Since 
oxidized LDL did not affect the downstream pathway located in the smooth muscle, 
one possible mechanism was that oxidized LDL could prevent the NO to activate the 
downstream pathway. Results obtained from western blotting analysis further 
supported the present findings that oxidized LDL did not affect the expression level of 
endothelial nitric oxide synthase (eNOS). The reduced nitric oxide activity in oxidized 
LDL-treated rings was not due to the reduced eNOS level. A simplified diagram 
showed the proposed mechanism in Figure 2.16. The present result was in agreement 
with that of Myers et al., (1994), who suggested that oxidized LDL directly inactivate 
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Figure 2.16 
Proposed mechanisms by which oxidized LDL inactivate inhibit the NO 
produced by eNOS and SNP. 
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NO, but did not affect NO production. Another possible mechanism suggested by 
Mukherjee et al. (2001) was that oxidized LDL stimulated PKC activity, which in turn 
increased the phosphorylation of the Gi-protein. Inhibition of Gi-protein then led to 
reduced release of NO from endothelial cells and thus caused endothelial dysfunction. 
The present study also found that treatment with a-tocopherol in oxidized 
LDL-treated rings partially improved the acetylcholine-induced 
endothelium-dependent relaxation. Since incubation with a-tocopherol itself did not 
influence the endothelial fiinction of aortic rings and eNOS expression level, it may 
be due to the interaction between a-tocopherol and oxidized LDL. Being a strong 
antioxidant, a-tocopherol plays an important role in the improvement of impaired 
acetylcholine-induced relaxation by oxidized LDL (Koul et. al, 2003; Amann et al 
2002; Balz et al； 1993). It was also found that increase in the concentration of 
a-tocopherol from 20 |xM to 100|iM did not further improve the maximum relaxation 
I 
caused by acetylcholine (51.0 土 8.2o/o in 20 |aM，52.7 土 13.3o/o in 40 |aM and 66.9 土 
8.46% in 100 ^M), meaning that 20 |iM a-tocopherol was already an ideal 
concentration to prevent LDL oxidation. It was also found that treatment with 
a-tocopherol in rings after co-incubation of native LDL and copper(II) sulphate 
resulted in a greater improvement on acetylcholine-induced endothelium-dependent 
relaxation when compared to that of oxidized LDL. Since a-tocopherol showed its 
strong antioxidant activity, it prevented the oxidation of native LDL mediated by 
copper(II) ions. As shown in Figure. 2.14D, only a small amount of native LDL was 
oxidized at the end of incubation period and a-tocopherol reduced the production of 
oxidized LDL, so that the inhibitory effect on acetylcholine-induced 
concentration-dependent relaxation was reduced. In this case, Figure 2.14C shows a 
greater Emax than that in the case of a-tocopherol pretreatment in the presence of 
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oxidized LDL (Figure 2.13C). It was also found that 20 \lM a-tocopherol was already 
enough to prevent the oxidation of native LDL from Copper(II) sulphate (1.7 土 0.4o/o 
LDL was oxidized in 20 |xM a-tocopherol, 1.0 土 0.2o/o in 40 |xM a-tocopherol, 0.7 土 
0.17% LDL in 100 |iM a-tocopherol). Further increase in the concentration of 
a-tocopherol from 20 to 100 |iM did not further improve the impaired 
acetylcholine-induced relaxation. In the past few decades, Intensive researches have 
been studying the prevention of a-tocopherol on the formation of oxidized LDL, 
scientists are all concerning the antioxidant activity of a-tocopherol (Chen et al., 2000; 
Devaraj et al., 2000; Thomas et al” 2000). However, there are few studies about 
whether a-tocopherol can reduce the problem caused by the formed oxidized LDL. 
One of the study done by van Aalst et al. (2004), who demonstrated that a-tocopherol 
could prevent atherogenesis by restoration of the endothelial monolayer injuried by 
oxidized LDL. The present study is the first report to demonstrate that a-tocopherol 
can partially restore the endothelial function when endothelium was previously 
1 
injured by oxidized LDL. 
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Chapter 3 
Effect of LDL injection on the endothelial 
function of rats 
3.1 Introduction 
The previous chapter demonstrated that oxidized LDL could impair 
acetylcholine-induced endothelium-dependent relaxation in vitro. Since 
atherogenesis or impairment of endothelium caused by oxidized LDL is a long-term 
process in the body, short term in vitro incubation of aortic rings with oxidized LDL 
may not reflect the in vivo actual situation. In the body, there are some mechanisms 
that protect against the oxidation of LDL and reduce the adverse effect of oxidized 
LDL once it is formed. Previous studies have shown that a serum enzyme, 
paraoxonase, has an anti-oxidant role in protecting LDL against oxidative 
modification (Boemi et al., 2001). Another investigation suggested that a 
HDL-assoicated enzyme lecithin-cholesterol acyltransferase (L-CAT) prevent 
accumulation of oxidized lipids in LDL (Vohl et al., 1999). However, in vitro 
investigation cannot account for the effects of all the mechanisms that prevent the 
adverse effect of oxidized LDL. Despite extensive in vitro data, the in vivo relevance 
of findings is not clearly known. Thus, an in vivo study about the effect of oxidized 
LDL on endothelium is necessary. 
Most of the previous in vitro studies used the pre-oxidized LDL prepared by 
the copper-mediated oxidation method (Travis et. al, 1998; Mougenot et al., 1997). 
However, copper was not a major oxidizing agent in vivo. In fact, free radical attacks 
and enzymatic modifications are the major causes of LDL oxidation (Mertens et. al., 
2001). Thus, the oxidized LDL formed in vivo may not be the same as the oxidized 
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LDL formed by copper-mediated method. The present study was to study the effect 
of oxidized LDL on endothelium-dependent relaxation in vivo by intravenous 
injection of native LDL into rats, which can avoid the use of copper-mediated 
method for the preparation of oxidized LDL. According to one previous study 
(Calara et al., 1998), intravenous injection of human LDL did not cause any adverse 
immune response in rats. A sudden and large quantity of injected native LDL caused 
rapid accumulation of LDL in arterial wall peaked at 12 hours, whereas the 
accumulated LDL was oxidized within 24 hours. 
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3.2 Objective 
The objective of the present study was to investigate the effect of LDL 
injection on lipid profile and endothelium-dependent vasorelaxation in rats. 
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3.3 Methods and Materials 
3.3.1 Preparation of Drugs 
Phenylephrine hydrochloride, acetylcholine hydrochloride, Sodium 
nitroprusside (SNP), Thapsigargin and N^-nitro-L-arginine methyl ester (L-NAME) 
were purchased from Sigma Co, Japan. 
3.3.2 Preparation of LDL 
Human LDL was prepared as described in part 2.3.2. 
3.3.3 Animal Treatment 
The experimental protocol was approved by the Animal Ethical Committee of 
the Chinese Univeristy of Hong Kong, Sprague-Dawley rats (n=18, 250-280g) were 
purchased from the CUHK Laboratory Animal Services Center and blood (0.5 mL) 
from each rat was collected via the ophthalmic venous plexus. Rats were then 
divided into three groups (one group was the Control while the rest two were 
assigned as Day 3 and Day 7 groups, respectively). For tail injection of LDL, rats 
were firstly anesthetized with sodium pentobarbital (40mg/kg, i.p.). For both Day 3 
and Day 7 groups, rats received intravenous injection of native LDL (4 mg/kg) via 
the tail. For the Control group, rats received intravenous injection of same volume of 
0.9% saline via the tail. 
Day 3 group was killed at the day after tail injection, while the Control 
and Day 7 groups were killed at the day after tail injection. In brief, rats were 
killed with pure carbon dioxide. Blood was collected from the abdominal aorta. 
Thoracic aorta was dissected out for organ bath experiment. Body weight was 
recorded and food consumption was recorded every day. 
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3.3.4 Serum lipid and lipoprotein determinations 
Serum TG and TC levels were determined using enzymatic kits (Sigma 
Chemical, St. Louis, MO, USA). HDL-C was measured after precipitation of LDL 
and VLDL with phosphotungstic acid and magnesium chloride, using a commercial 
kit (Sigma Chemical, St. Louis, MO, USA). 
3.3.5 Measurement of serum MDA level by TEARS assay 
Serum was firstly obtained by centrifugation of blood at 3,000g for 5 minutes. 
The serum was then diluted by 30 times with saline for TEARS assay. The diluted 
serum was firstly mixed with 2 ml of 0.67% thiobarbituric acid and 15% 
trichloroacetic acid in O.IN HCl solution. The incubation mixture was then heated at 
95°C for 1 hour, cooled on ice, and centrifuged at 1500 g for 10 minutes. TEARS 
was determined by measuring the absorbance at 532 nm. Calibration was done with 
a malondialdehyde (MDA) standard solution prepared from tetramethoxylpropane. 
t 
The value was expressed as nmol MDA/mg LDL protein (Buege et al” 1978). 
3.3.6 Preparation of aorta. 
The endothelium-intact aortic rings were prepared as described in part 2.3.4. 
For endothelium-denuded rings, similar method was applied with some modification. 
After a 3mm ring segment was cut out, the endothelial layer was mechanically 
removed by gently rubbing the luminal surface back and forth several times with a 
stainless steel wire. Removal of the endothelium was confirmed by the absence of a 
relaxant response to 1 i^M acetylcholine at the beginning of each experiment. 
Endothelium denudation was also evaluated by light microscopy of histological 
sections of rings. 
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3.3.7 Organ bath experiment 
For the first set of experiment, both endothelium-intact and -denuded rings 
were used. Two consecutive response curves to phenylephrine were produced. For 
the first consecutive curve, a control concentration-contraction curve for different 
concentration of phenylephrine was produced. After that, all rings were then rinsed 
several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored. Before the construction of second concentration-contraction curve to 
phenylephrine, rings were treated with 100 i^M L-NAME. 
In the second set of experiment, endothelium-intact rings were used. After the 
confirmation of the presence of endothelium in endothelium-intact rings, two 
concentration-response curves were constructed. For the first concentration response 
curve, rings were contracted with Ijj-M phenylephrine and then 
concentration-dependent relaxation to acetylcholine was produced. After the first 
concentration response curve, all rings were then rinsed several times with 
pre-warmed Krebs-Henseleit solution until basal tension was restored. For the 
second concentration-response curve, rings were contracted with l|iM 
phenylephrine and then concentration-dependent relaxation to thapsigargin was 
produced. 
‘ In the third set of experiment, endothelium-denuded rings were used. After the 
confirmation of the absence of endothelium in endothelium-denuded rings, two 
concentration-response curves were constructed. For the first concentration response 
curve, rings were contracted with IfxM phenylephrine and then 
concentration-dependent relaxation to sodium nitropmsside was produced. After the 
first concentration response curve, all rings were then rinsed several times with 
pre-warmed Krebs-Henseleit solution until basal tension was restored For the 
second concentration-response curve, rings were contracted with IjiM 
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phenylephrine and then concentration-dependent relaxation to isoprenaline was 
produced 
3.3.8 Statistics 
Results were expressed as percentage relaxation of the agonist-constricted 
arterial rings. Data were presented as means 土 SD of n experiments. Statistical 
significance was analyzed by Student's t-test or by one way ANOVA followed by 
Newman-Keuls test when more than two treatments were compared. Statistical 




3.4.1 Growth and food intake 
The body weight gain and food intake of rats are shown in Table 3.1. No 
significant differences in body weight and food intake were observed among the 
Control, Day 3 and Day 7 groups. 
3.4.2 Effect of LDL injection on serum TC, TG and HDL-C 
Significant increase in serum TC was observed in Day 3 and Day 7 groups 
when compared with the value of the Control group (P<0.05). Serum TC of Day 7 
was the highest (Table 3.2). To be specific, the serum TC in Day 3 and Day 7 groups 
was 20.5% and 27.3% higher than that in the Control group, respectively. For serum 
TG and HDL, there were no significant differences among the three groups (Table 
3.2). 
I 
3.4.3 Effect of LDL injection on non-HDL-C and ratio of non-HDL-C to 
HDL-C 
Non-HDL-C was defined as a difference between TC and HDL-C. 
Non-HDL-C levels for the Control, Day 3 and Day 7 were 43.8 士 4.2，63.6 土 8.3 and 
64.5 土 9.6 mg/ dL, respectively. 
Non-HDL-C was increased by 45.2% and 47.3% in Day 3 and Day 7 groups, 
respectively, when compared with that in the Control group (Table 3.2). The ratio of 
non-HDL-C to HDL-C in Day 3 and Day 7 groups was found to be significantly 
higher than that of the Control group (Table 3.2). 
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Table 3.1 
Changes in body weight and food intake.  
Control Day 3 Day 7 
Initial body wt (g) 263.6 ± 11.0 264.3 土 8.9 264.5 土 4.2 
Final body wt(g) 273.1 土 6.3 273.5 土 13.0 274.8 ±4.7 
Food intake (g/day) 13.2 ±0.2 12.9 ±0.3 14.0 ±0.2 




Effect of LDL injection on levels of serum triglycerides (TG), total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), non-HDL-C and the ratio 
of non-HDL-C to HDL-C.  
Control Day 3 Day 7 
TC (mg/dL) 72.5 土 7.5b 87.4 土 92.3 土 
TG (mg/dL) 90.3 ± 11.5 92.9 ±9.6 90.8 ±13.0 
HDL (mg/dL) 28.7 土 4.7 23.8 ±4.9 25.8 ± 5.5 
Non-HDL (mg/dL) 43.8 ±4.2^ 63.6 ± 8.3a 64.5 ± 9.6a 
non-HDL/HDL 1.5 ± Ojb 2.7 土 0.5a 2.5 土 
Data are expressed as mean 土 SD (n=6) 
Non-HDL-C = (TC) - (HDL-C) 
Means at the same row with different superscripts (a, b) differ significantly (p< 
0.05) 
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3.4.4 Serum MDA level 
Injection of LDL at the dose of 4mg/kg caused a significant increase in 
concentration of serum MDA (P<0.05). The Control group had 6.1 土 0.7 nmol/ml 
MDA in serum, while Day 3 and Day 7 rats had 10.0 土 0.7 and 11.6 ± 0.8 nmol/ml 
MDA in serum, respectively. A significant difference in serum MDA concentration 
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Control Day 3 Day 7 
LDL Injection 
Figure 3.3 
Serum MDA concentration in rats at day 3 and day 7 after tail injection of 
native LDL. Data are expressed as mean 土 SD (n=6). Means with different 
letters (a, b, c) differ significantly (p< 0.05). 
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3.4.5 Phenylephrine-induced contraction 
In order to assess whether injection of LDL reduced endothelial NO release, 
two concentration-contraction curves for phenylephrine were generated in aortic 
rings before and after treatment with L-NAME respectively. The degree of enhanced 
-contraction following inhibition of the NO pathway reflected the influence of basal 
and agonist-stimulated NO release on vessel contraction. Normally, phenylephrine 
could cause contractile responses in two consecutive concentration-response curves 
with similar potency in aortic rings without any treatment (data not shown). Tracings 
in Figure 3.4 show that treatment with L-NAME (100 |xM) enhanced 
phenylephrine-induced concentrations in endothelium-intact aortic rings from all 
three groups. It was also found that aortic rings from Day 3 (Figure 3.5B) and Day 7 
(Figure 3.5C) groups exhibited smaller augmentation of the phenylephrine 
contraction after treatment with L-NAME (inhibition of NOS) as compared to those 
from the Control group (Figure 3.5A). Figure 3.6A shows smaller L-NAME 
sensitive tone of aortic rings in Day 3 and Day 7 groups than that in the Control 
groups. Whereas, L-NAME sensitive tone in endothelium-denuded rings was 
markedly reduced and similar in all three groups (Figure 3.6B). 
The present experiment found that the contractile responses of 
endothelial-intact rings caused by phenylephrine in Day 3 and Day 7 groups were 
significantly higher than that of the Control group (Figure 3.7A), but there was no 
significant difference between Day 3 and Day 7 groups. There was no significant 
difference on contractile responses in endothelial-denuded rings (Figure 3.7B) and 
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Figure 3.4 
Representative traces show two consecutive-dependent contractions to 
phenylephrine in the absence and present of L-NAME in endothelium-intact 
aortic rings. Scale bars apply to all records. 
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Figure 3.5 
Concentration-response curves for phenylephrine obtained in aortic rings 
from (A) control, (B) Day 3 and (C) Day 7 groups in the absence and 
presence of L-NAME. Rings were exposed to 100 |JM L-NAME 30 min before 
repeating the second concentration-response curve. Data are expressed as 
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Figure 3.6 
L-NAME sensitive component of phenylephrine-induced contractions was 
determined by subtracting the first (control, without L-NAME) from the second 
(with L-NAME) concentration-response curve at each data point for 
endothelium (A) -intact and (B) -denuded aortic rings from control, Day 3 and 
Day 7 groups. Data are expressed as mean 土 SD (n=6). 
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Figure 3.7 
Maximum Phenylephrine-induced tension is expressed as mN per milligram 
dry weight of aortic rings. Results were obtained in rings in the (A) presence 
and (B) absence of endothelium, and (C) endothelium-intact rings treated 
with L-NAME. Data are expressed as mean 土 SD (n=6). Means with different 
letters (a, b) differ significantly (p< 0.05). 
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3.4.6 Endothelium-dependent and -independent relaxation 
For endothelium-dependent relaxation, LDL injection significantly reduced the 
acetylcholine-induced relaxation in Day 3 (Emax: 68.08 土 0.52o/o, pDi： 6.46 土 0.05) 
and Day 7 group (Emax: 57.73 土 1.330/0，6.55 土 0.06) when compared to that of 
the Control group (Emax: 76.12 土 3.85o/o，/7D2: 6.91 土 0.04) (P<0.05, Figure 3.8). 
Thapsigargin-induced endothelium-dependent relaxation was also significantly 
reduced in Day 3 (Emax： 76.43 土 2.69o/o, pD2： 8.22 土 0.08) and Day 7 group (Emax: 
67.94 土 3.090/0，；?D2: 8.13 土 0.12) when compared to the Control group (Emax： 89.27 
土 4.52%，;7D2: 8.56 ±0.15) (P<0.05, Figure 3.9). 
For endothelium-independent relaxation, there are no significant differences in 
SNP-induced relaxation among the three groups (Control, Emax: 87.65 土 9.99%,冲2: 
6.99 土 0.26; Day 3，Emax: 92.02 土 3.40o/o, pDi： 6.93 土 0.24; Day 7，Emax： 85.09土 
5.\0yo,pT>2： 6.70 土 0.25) (P<0.05, Figure 3.10). 
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Figure 3.8 
(A) Concentration-response curves for phenylephrine-induced contractile 
responses and acetylcholine-induced concentration-dependent relaxation in 
rat endothelial-intact rings. (B) pD2 values (-log IC50) for acetylcholine. (C) The 
maximal relaxation (Emax %) induced by acetylcholine. Data are expressed as 
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Figure 3.9 
(A) Concentration-response curves for phenylephrine-induced contractile 
responses and thapsigargin-induced concentration-dependent relaxation in rat 
endothelial-intact rings. (B) pD2 values (-log IC50) for thapsigargin. (C) The 
maximal relaxation (Emax %) induced by thapsigargin. Data are expressed as 
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Figure 3.10 
(A) Concentration-response curves for phenylephrine-induced contractile 
responses and SNP-induced concentration-dependent relaxation in rat 
endothelial-denuded rings. (B) pD2 values (-log IC50) for SNP. (C) The maximal 




The present study demonstrated that injection of LDL significantly increased 
the level of serum TC, non-HDL-C and the ratio of non-HDL-C to HDL-C，but it did 
not affect the level of serum TG and HDL-C. It was found that there was a dramatic 
elevation of TC and non-HDL-C in rats. Day 3 and Day 7 groups exhibited 14.9 土 1.3 
mg/dL and 19.8 土 1.9 mg/dL increase in TC respectively, and 19.8 土 2.1 mg/dL and 
20.7 ± 2.5 mg/dL increase in non-HDL respectively. According to one previous study, 
rats have total blood volume of about 7% of its body weight (Lee et al., 1985). By a 
calculation, it was found that Day 3 and Day 7 groups had TC increased by net 2.7 土 
0.4 mg and 3.7 土 0.4 mg absolute amount of TC increased in the total blood, 
respectively, and had non-HDL cholesterol increased by net 3.7 + 0.4 mg and 3.8 + 
0.5 mg, respectively. Since each rat only received 4mg/kg (1 mg in a 260g rat) native 
LDL injection, the dramatic elevation in TC and non-HDL-C obviously was not due 
to the extra LDL cholesterol injected, suggesting that human native LDL had 
hypercholesterolemic effects on rat and also caused the redistribution of serum 
cholesterol. This is the first study to demonstrate the hypercholesterolemic effect of 
human LDL on rats. 
The present results also demonstrated that intravenous injection of human native 
LDL increased the oxidative stress in rats. This was reflected by the observation that 
the MDA level was significantly increased from Day 3 to Day 7 after the LDL 
injection. It may be due to the oxidation of native LDL into oxidized LDL. Previous 
studies showed that a single injection of native LDL (4mg/kg) caused a rapid 
accumulation of LDL in the arterial wall, where it was oxidatively modified within 6 
to 12 hours, and induced inflammatory reaction in the arterial walls in rats (Calara et 
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a!.’ 1998). The present result was in agreement with that of Jiang et al. (2002), who 
also demonstrated that intravenous injection of human native LDL increased serum 
MDA level in rats. 
The present study showed that aortic rings of LDL-injected rat (Day 3 and Day 7 
groups) exhibited a higher sensitivity of phenylephrine-induced contractions in the 
presence of L-NAME as compared to those of non-LDL-injected (Control) group. 
Furthermore, the active contractile responses (net contractile force) to phenylehprine 
were greater in Day 3 and Day 7 groups when compared to contractions in the Control 
group. However, concentration-dependent contractions to phenylephrine in the 
presence of L-NAME or absence of endothelium were similar among the Control, 
Day 3 and Day 7 groups. NO is derived from its precursor, L-arginine, and its 
synthesis is prevented by L-NAME (eNOS inhibitor). Once released from endothelial 
cells, NO readily diffuses towards the underlying vascular smooth muscle cells and 
acts to stimulate the relaxation of smooth muscle. Differences in basal NO release 
should be indirectly reflected as the differences in the contractile responses to a 
vasoconstrictor before and after treatment with L-NAME (Bolton et al., 1996). The 
present data clearly indicated that basal release of NO was significantly reduced in 
Day 3 and Day 7 groups. This was further supported by the reduced L-NAME 
sensitive tone in Day 3 and Day 7 groups when compared with that of the Control 
group. There was no significant difference in L-NAME sensitive tone between Day 3 
and Day 7 groups, suggesting that 3 days was the optimum period of time to cause the 
reduction in basal NO release after LDL injection. 
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The present study demostrated that LDL injection impaired 
endothelium-dependent vasorelaxation, and the acetylcholine- and thapsigargin 
-induced relaxations Acetylcholine is a receptor-dependent vasodilator, which 
stimulates Mi and M2-muscarinic receptors, while thapsigargin is a 
receptor-independent vasodilator, which directly inhibit sarco-endoplasmic reticulum 
2+ 
(SR) Ca -ATPase. The results suggested that LDL injection impaired the NO balance 
of the endothelial cells, but it did not affect the affinity of receptor for vasodilators. 
Although other studies suggested that oxidized LDL impaired both receptor and 
non-receptor-mediated vasodilations in porcine coronary artery, the discrepancy may 
be due to difference in species of animal and different artery used (Travis et al., 1998). 
Furthermore, LDL injection did not affect the SNP-induced relaxation, which is an 
endothelium-dependent vasodilator, suggested that LDL injection did not affect the 
mechanisms and biochemical pathway on the smooth muscle cells. It was concluded 
that the oxidized LDL generated after LDL injection only affected the endothelial 
cells or NO balance. Several mechamims have been proposed in previous studies, 
including direct inactivation of NO (Chin et al； 1992), enhancement by oxidized LDL 
of endothelial superoxide production (Galle et al., 2000)，redistribution of NO 
synthase (Blair et al., 1999) and reduced endothelial NO synthase expression 
(Hermandez et al., 1998). Also, by considering the acetylcholine and thapsigargin 
responses between Day 3 and Day 7 groups, the impairment on the endothelium was 
more potent for a longer exposure to oxidized LDL. The present results were 
consistent with the study conducted by Jiang et al. (2002)，who reported that 
vasoconstrictor responses to phenylephrine were significantly increased and 
vasodilator responses to acetylcholine were significantly reduced for up to 3 days 
after LDL injection. 
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The present study in rats, although not directly applicable to humans, may have 
some implications for adverse effect of oxidized LDL on cardiovascular function. The 
present study demonstrated clearly that human LDL injection increased oxidative 
stress and caused reduction in artery relaxation in rats. The effect of injected human 
LDL was most likely mediated by its action on endothelium but not on the smooth 
muscle. It is known that LDL composition is a function of diet. It will be of interest if 




Effects of individual component of oxidized LDL 
on endothelium-dependent relaxation 
4.1 Introduction 
Results obtained in Chapter 2 have shown that oxidized LDL can impair 
endothelial function and that this can be partially overcome in vitro by addition of 
a-tocopherol. However, it is unclear whether this effect of oxidized LDL is due to 
lysophophatidylcholine (LPC) (Froese et al., 1999), cholesterol oxidation product 
(COP) (Bhadra et al., 1991) or other components of oxidized LDL, and it is also 
uncertain if the protective effect of a-tocopherol is related to its antioxidant properties 
(Chan et. al, 2003). 
Several mechanisms have been proposed for the inhibition of 
endothelium-dependent relaxation by oxidized LDL, including direct inactivation of 
nitric oxide (NO) (Chin et al., 1992)，enhancement by oxidized LDL of endothelial 
superoxide production, which then inactivates NO (Cominacini et al., 2001; Galle et 
al., 2000), redistribution of endothelial NO synthase (Blair et al” 1999)，reduced 
endothelial NO synthase expression (Hemandez-Perera et al., 1998)，increased 
cytosolic calcium levels (Zhao et al., 1997) and inhibition of endothelium-dependent 
hyperpolarizing activity (Eizawa et al., 1995). The effect on endothelium-dependent 
relaxation is only specific to oxidized LDL and is not seen in native LDL or 
acetylated LDL. 
During oxidation of LDL, the components of LDL undergo dramatic change by 
interaction with oxygen to form oxidation products, such as LPC, COPs and oxidized 
fatty acids (Goto et al., 1982). For the COPs, with reference to previous studies 
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(Bhadra et al., 1991; Jialal et al., 1991; Tamasawa et al., 1992; Zhang et al； 1990)， 
major cholesterol derivatives generated in oxidized LDL are a-hydroxycholesterol, 
7P-hydroxycholesterol and 7-ketocholesterol. LPC is formed during oxidation through 
the hydrolysis of oxidized phosphatidylcholine by platelet-activating factor (PAF) 
acylhydrolase (Steinbrecher et al., 1984; 1989). However, the component(s) of 
oxidized LDL that inhibit endothelium-dependent relaxation activity have not been 
completely confirmed by previous studies, although previous investigators believed 
that LPC and 7-ketocholesterol are the 2 major components involved in the 
impairment of endothelium-dependent relaxation (Kugiyama et al., 1990; Plane et al., 
1992; Tanner et. al, 1991, Yokoyama et al., 1990). The effect of LPC and 
7-ketocholesterol involves both protein kinase C (PKC) and PKC-independent 
mechanisms. Both the LPC and 7-ketocholesterol can activates PKC, causing an 
interruption on the NO relaxing system, and thus, affect the endothelium-dependent 
relaxation. However, there is a controversy as to whether the effect of oxidized LDL 
can be explained solely by LPC and 7-ketocholesterol, perhaps due to differences in 
the extent of oxidation in these studies (Kikuta et al., 1998; Plane et al., 1992). 
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4.2 Objectives 
The present study was to determine the compositional differences between native and 
oxidized LDL and to determine the effect of the individual components on 
endothelium-dependent relaxation. 
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4.3 Materials and methods 
4.3.1 Preparation of drugs 
Triheptadecanoate, 5a-hydroxycholesterol, 7a-hydroxycholesterol, 
7|3-hydroxycholesterol, 25-hydrocholesterol and 7-ketocholesterol, 
lysophosphatidylcholine were purchased from Sigma Co (Chicago, USA). 
7a-hydroxycholesterol, 7p-hydroxycholesterol, 7-ketocholesterol and 
lysophosphatidylcholine were dissolved in ethanol, whereas others were dissolved in 
Nano pure water. Ethanol at 0.2% (20 |il in 10 mL) did not affect the sustained 
contraction induced by phenylephrine. 
4.3.2 Preparation of human native LDL and oxidized LDL 
Human LDL and oxidized LDL were prepared as described previously in 
Chapter 2. 
4.3.3 GC analysis of fatty acid composition in LDL 
To analyze the fatty acid composition of native and oxidized LDL, 2mg 
triheptadecanoate (internal standard) was added to 5 mg of native and oxidized LDL 
in separate tubes, which were then extracted with 10 ml of chloroform: methanol (2:1) 
followed by centrifiigation at 3,000 rpm for 10 min. The organic phase was obtained 
and dried under a gentle stream of nitrogen. Boron trifluoride (2 ml) in methanol 
(14%) and 1 ml of toluene were added to methylate the samples. All tubes were 
flushed with nitrogen before capped. The samples were heated at 90°C for 1 hr. After 
that, samples were extracted by 3 ml hexane and 1 ml distilled water. Ogranic phase 
was obtained by centrifugation at 2,000 rpm for 10 min. The samples were then dried 
under a gentle stream of nitrogen and 0.8 ml hexane was added and samples were then 
subjected to GC analysis. 
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For GC analysis, Hewlett-Packard 5890 serious II gas chromatography 
equipped with a flame ionization detector and a flexible fused silica capillary column 
(Innowax 19091N-213, 30m x 0.32mm i.d.，Alltech, Inc., USA) was used. The 
column temperature was set at 180°C, gradually increased to 230°C with a rate of 
2°C/min, and was then maintained at 230°C for 5 min. The injector and detector were 
maintained at 250°C and 300°C respectively. Helium was used as a carrier gas at a 
head pressure of 15 psi. Typical chromatogram of fatty acids was shown in Figure 4.1. 
4.3.4 TEARS assay analysis of MDA content in LDL 
LDL (5 mg protein/ml) was mixed with 2 ml of 0.67% thiobarbituric acid and 
15% trichloroacetic acid in O.IN HCl solution. The incubation mixture was then 
heated at 95°C for 1 hour, cooled on ice, and centrifUged at 1500 g for 10 minutes. 
TEARS was determined by measuring the absorbance at 532 nm. Calibration was 
done with a MDA standard solution prepared from tetramethoxylpropane. The value 
was expressed as nmol MDA/mg LDL protein (Buege et al., 1978). 
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Figure 4.1 
Gas liquid chromatogram of fatty acids. Identification of peaks: 
1, 16:0; 2，16:1; 3’ 17:0 (Internal Standard); 4，18:0; 5，18:1(n-9); 6，18:2(n-6); 
7, 18:3(n-3); 8, 20:4(n-6) and 9，22:6(n-3) 
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4.3.5 GC analysis of cholesterol oxidation products in LDL 
Native and oxidized LDL (1 mg each) was used to determine the cholesterol 
composition. In brief, the LDL and 1 mg 5 a -cholestane, as an internal standard, were 
extracted with 15 mL chloroform-methanol (2:1, v/v). The chloroform-methanol 
phase was removed and dried by flushing with nitrogen. After 1 hour mild 
hydrolysis with 5 mL IN NaOH in 90% ethanol at 90 °C, 1 mL of water and 6 mL of 
cyclohexane were added for extraction of cholesterol. The cyclohexane phase was 
evaporated to dryness under nitrogen, and cholesterol was converted to its TMS-ether 
erivative by a commercial TMS-reagent (dry pyridine-hexamethyldisilazane-
trichlorosilane, 9: 3: 1，v/v/v, Sil-A regent, Sigma). After 1 hour at 60 the 
mixture was dried by flushing with nitrogen. The TMS-ether derivative was dissolved 
in 500 [iL of hexane, and after centrifugation, the hexane phase was transferred to a 
vial for gas-liquid chromatograph (GLC) analysis. The TMS-ether derivative was 
analyzed in a fused silica capillary column (SAC™-5, 30 m x 0.25 mm, i.d.; Supelco, 
Inc., Bellefonte, PA, USA) in a Shimadzu GC-14B GLC equipped with a 
flame-ionization detector (Shimadzu). The column temperature was set at 285°C 
and maintained for 20 minutes. Helium was used as carrier gas at a head pressure of 
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Figure 4.2 
Gas liquid chromatogram of cholesterol oxidation products (COPs). 
Identification of peaks: 1， 5 a -cholestane (internal Standard); 2, 
5a-hydroxycholesterol； 3, 7a-hydroxycholesterol； 4, 7P-hydroxycholesterol； 5, 
7-ketocholesterol; 6, 25-hydroxycholesterol 
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4.3.6 Thin-layer chromatography analysis of LPC in LDL 
Native LDL and oxidized LDL (1 mg each) were extracted with 10 ml of 
chloroform imethanol (2:1). The organic phase was then dried under a gentle stream 
of nitrogen. After that, 0.12 mL chloroform was added and vortexed until the solid 
dissolved. The sample was then spotted onto a thin-layer chromatography plate 
(20x20cm, silica gel 60 F254, Merck Co.). The TLC plate was allowed to develop in 
hexane: diethyl ether: acetic acid (80:20:1) for 45 mins. After that, the plate was dried 
and the band corresponding to LPC standard was removed from the plates into a 
methylation tube. Heptadecanoic acid (0.2 mg) was added into the tube. Sample was 
methylated by addition of 1 ml toluene and 2 ml 14% BF3 in methanol and heated at 
90�C for 1 hour. The methylation product was extracted by 3ml hexane and 1 ml 
distilled water. Ogranic phase was obtained by centrifugation at 2,000 rpm for 10 min. 
The samples were then dried under a gentle stream of nitrogen and 0.8ml hexane was 
added and samples were then subjected to GC analysis. 
For GC analysis, Hewlett-Packard 5890 serious II gas chromatography 
equipped with a flame ionization detector and a flexible fused silica capillary column 
(Innowax 19091N-213, 30m x 0.32mm i.d., Alltech, Inc., USA) was used. The 
column temperature was set at 180°C and gradually increased to 230°C with rate of 
increase at 2°C/min. Temperature at 230°C was maintained for 5 min. The injector 
and detector were maintained at 250°C and 300°C respectively. Helium was used as 
carrier gas at a head pressure of 15 psi. 
4.3.7 Preparation of aorta 
Rat aortic rings were prepared as described previously in Chapter 2. 
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4.3.8 Measurement of Isometric Force in vitro 
4.3.8.1 Protocol 1- effect ofLPC on acetylcholine-induced vasorelaxation 
After testing each ring's integrity of the endothelial layer, a plateau 
contraction was obtained after addition of l|xM phenylephrine to the bathing solution 
and then concentration-dependent relaxation by acetylcholine was produced. They 
were then rinsed several times with pre-warmed Krebs-Henseleit solution until basal 
tension was restored and the second concentration-response curve by acetylcholine 
was produced again. In order to test effect of LPC, rings were exposed to 9.77 |xg/ml 
LPC for 30 mins prior to the second concentration-dependent relaxation by 
acetylcholine. 
4.3.8.2 Protocol 2- effect of cholesterol oxidation products on acetylcholine-induced 
vasorelaxation 
After testing each ring's integrity of the endothelial layer, a plateau contraction 
was obtained after addition of l|aM phenylephrine to the bathing solution and then 
concentration-dependent relaxation by acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve by acetylcholine was produced 
again. In order to test effect of COP, rings were exposed to individual Cholesterol 
oxidation products (2.62 |ig/ml 5a-hydroxycholesterol, 1.29 |xg/ml 7-ketocholesterol, 
8.61 |ig/ml 7a-hydroxycholesterol, 7.87 |xg/ml 7P-hydroxycholsterol, 0.59 (xg/ml 
25-hydrocholesterol or the mixture of these 5 COPs) for 30 mins prior to the second 
concentration-dependent relaxation by acetylcholine. 
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4.3.8.3 Protocol 3- effect of oxidized fatty acids on acetylcholine-induced 
vasorelaxation 
After testing each ring's integrity of the endothelial layer, a plateau contraction 
was obtained after addition of Ij^M phenylephrine to the bathing solution and then 
concentration-dependent relaxation by acetylcholine was produced. They were then 
rinsed several times with pre-warmed Krebs-Henseleit solution until basal tension was 
restored and the second concentration-response curve by acetylcholine was produced 
again. In order to test effect of oxidized fatty acids, rings were exposed to 25.0 |xg/ml 
oxidized linoleic acid or 0.58 |J^ g/ml linolenic acid for 30 mins prior to the second 
concentration-dependent relaxation by acetylcholine. 
4.3.9 Statistics 
Results were expressed as percentage relaxation of the agonist-constricted 
arterial rings. Data was presented as means 土 SD of n experiments. Statistical 
significance was analyzed by Student's t-test or by one way ANOVA followed by 
Newman-Keuls test when more than two treatments were compared. Statistical 
difference was considered significant when p<0.05. 
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4.4 Results 
4.4.1 Compositional differences between native LDL and oxidized LDL 
Decrease in the triglyceride and cholesterol but increase in production of LPC 
and MDA were observed in oxidized LDL. In addition, significant alterations in the 
overall fatty acids composition of oxidized LDL were also observed. The oxidation 
step did not modify the level of the two major saturated fatty acids, i.e. palmitic (16:0) 
and stearic acids (18:0). In contrast, monounsaturated fatty acids were significantly 
reduced by oxidation, such as palmitoleic acid (16:1)，that decreased from 32 ± 10 
mg/g to 18 土 2 mg/g and oleic acid (18:1) decreased from 223 土 6 mg/g to 200 土 7 
mg/g and, to a greater extent, polyunsaturated fatty acids, such as linoelic acid (18:2), 
that decreased from 592 土 24 mg/g to 343 土 6 mg/g, linolenic acids, that decreased 
from 10 ± 2 mg/g to 4 土 1 mg/g and arachidonic acid (20:4) decreased from 68 土 7 
mg/g to 34 ± 2 mg/g. (Table 4.1). 
The oxidation-induced decrease among various lipid species of LDL was 
associated with elevation of several lipid oxidation products, including MDA, COPs 
and LPC. After oxidation process, MDA content in oxidized LDL was significantly 
increased by 120-folds when compared to that of native LDL (Figure 4.3 A). The GC 
analysis demonstrated that 5a-hydroxycholesterol (28.1 + 4.5 mg/g), 
7-ketocholesterol (16.8 + 1.4 mg/g), 7a-hydroxycholesterol (87.4 + 7.2 mg/g), 
7p-hydroxycholsterol (81.6 + 8.8 mg/g) and 25-hydrocholesterol (7.3 + 1.0 mg/g) 
were the major cholesterol derivatives. Only trace amounts of individual cholesterol 
derivatives were detected in native LDL (Table 4.2). In fact, COPs content was 
increased by 27-folds in oxidized LDL (221.2 + 22.8 mg/g) compared with native 
LDL (8.1 + 1.2 mg/g) (Table 4.2). In addition, oxidation of LDL was also 
accompanied by an 8-folds increase in LPC content (Fig 4.3B). 
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Table 4.1 
Fatty acid compositions of native and oxidized LDL (mg/g LDL protein). 
Fatty acid Native LDL Oxidized LDL P 
Palmitic acid (16:0) 211 ± 4 210 ± 7 >0.05 
Palmitoleic acid (16:ln-7) 32 ± 10 18 土 2 <0.05 
Stearic acid (18:0) 52 土 3 53 ± 5 >0.05 
Oleic acid(18:ln-9) 223 ± 6 200 ± 7 <0.05 
Linoleic acid (18:2n-6) 592 土 24 343 土 6 <0.05 
Linolenic acid (18:3n-3) 10 土 2 4 ± 1 <0.05 
Arachidonic acid (20:4n-6) 68 土 7 34 ± 2 <0.05 
Values are expressed as means 土 SD (n=6). 
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Table 4.2 
Cholesterol oxidation products (COPs) compositions of native and oxidized 
LDL (mg/g LDL protein). 
COPs Native LDL Oxidized LDL P 
Cholesterol 189.9 土 10.20 0 <0.05 
Sa-hydrocholesterol 0 28.1 +4.46 <0.05 
7-ketocholesterol 4.2 土 0.22 16.8 ± 1.42 <0.05 
Ta-hydroxycholsterol 2.2 ±0.19 87.4 ±7.23 <0.05 
7p-hydroxycholesterol 0.2 ±0.10 81.6 ±8.76 <0.05 
5a,6a-expoxides 0.0 土 0.0 0.0 土 0.0 
25-hydroxycholesterol 1.5 土 0.77 7.3 土 0.96 <0.05 
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Figure 4.3 
(A) Amount of malondialdehyde (MDA) content of native and oxidized LDL (B) 
Amount of Lysophosphatidylcholine (LPC) content of native and oxidized LDL 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b) differ ignificantly at P<0.05. 
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4.4.2 Effect of LPC on endothelium-dependent relaxation 
In order to examine the effect of LPC on acetylcholine-induced relaxation, two 
consecutive concentration-response curves for acetylcholine were constructed. The 
first curve served as the control experiment. After the first concentration-response 
curves, rings were exposed to 9.77 |xM LPC for 30 mins, followed by second 
concentration-response curve and showed a small inhibition on 
endothelium-dependent relaxation (Fig 4.4A). The pD2 (-log IC50) values for 
aceylcholine-induced relaxation are presented in Fig 4.4B and the maximal relaxation 
(Emax %) induced by acetylcholine in Fig 4.4C. 
4.4.3 Effect of COPs on endothelium-dependent relaxation 
After the first concentration-response curves, rings were exposed to individual 
COPs (2.62 |ig/ml 5a-hydroxycholesterol, 1.29 i^g/ml 7-ketocholesterol, 8.61 |ig/ml 
7a-hydroxycholesterol, 7.87 |ig/ml 7P-hydroxycholsterol, 0.59 lig/ml 
25-hydrocholesterol or the mixture of these 5 COPs) for 30 mins, followed by a 
second concentration-response curve. Except for 5a-hydroxycholesterol and 
25-hydrocholesterol, all other COPs (includes 7-ketocholesterol, 
7a-hydroxycholesterol and 7|3-hydroxycholsterol) and COP mixture showed 
inhibition on endothelium-dependent relaxation and the effect of COP mixture was 
greater than that of the individual COP (Fig 4.5A). The pD2 (-log IC50) values for 
aceylcholine-induced relaxation are presented in Fig 4.5B and the maximal relaxation 
(Emax %) induced by acetylcholine in Fig 4.5C. 
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Figure 4.4 
Concentration-response curves for 1fjM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
lysophosphatidylcholine (LPC) on acetylcholine-induced concentration-
depentdent relaxation. (B) The pD2 values (-log IC50) for acetylcholine. (C) The 
maximal relaxation (Emax %) induced by acetylcholine. Values are expressed 
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Figure 4.5 
Concentration-response curves for 1pM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|jM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings, (a) Effect of 
different individual COPs and COP mixture on acetylcholine-induced 
concentration- depentdent relaxation, (b) The pD2 values (-log IC50) for 
acetylcholine, (c) The maximal relaxation (Emax %) induced by acetylcholine. 
Values are expressed as means 土 SD (n=6). Means with different letters (a, b， 
c, d) differ significantly at P<0.05. 100 
4.4.4 Effect of oxidized fatty acids on endothelium-dependent relaxation 
After the first concentration-response curves, rings were exposed to individual 
oxidized fatty acids (25.0 |xg/ml oxidized linoleic acid or 0.56 |xg/ml oxidized 
linolenic acid) for 30 mins, followed by a second concentration-response curve. It was 
found that oxidized linolenic acid did not cause any inhibition on 
endothelium-dependent relaxation while oxidized linoleic acid caused an inhibition on 
endothelium-dependent relaxation (Fig 4.6A). The pD2 (-log IC50) values for 
aceylcholine-induced relaxation are presented in Fig 4.6B and the maximal relaxation 
(Emax %) induced by acetylcholine in Fig 4.6C. 
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Figure 4.6 
Concentration-response curves for 1|JM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in rat endothelium-intact aortic rings. (A) Effect of 
oxidized linoleic acid (18:2) and oxidized linolenic acid (18:3) on 
acetylcholine-induced concentration- depentdent relaxation. (B) The pD2 
values (-log IC50) for acetylcholine. (C) The maximal relaxation (Emax %) 
induced by acetylcholine. Values are expressed as means 土 SD (n=6). Means 
with different letters (a, b) differ significantly at P<0.05. 102 
4,5 Discussion 
The previous chapter demonstrated that oxidized LDL inhibited the 
endothelium-dependent relaxation. It was generally believed that specific compounds 
of oxidized LDL might act permanently on the endothelial cells by modifying their 
relaxing function. 
Oxidation is known to induce dramatic changes in the structure and 
composition of LDL particles, including the peroxidation of unsaturated fatty acids 
and phosphatidylcholine, and the generation of cholesterol oxidation products and 
MDA. MDA was a by-product produced during oxidation of fatty acids. MDA can act 
as an indication of extent of LDL oxidation (Yoshiyuki et al； 2001). In the present 
study, LDL isolated from normolipidemic human plasma samples were oxidized in 
vitro with copper(II) sulphate, a widely used method that induced marked alterations 
in lipid content of LDL (Esterbauer et al., 1990). In accordance with previous studies 
(Kugiyama et. al, 1990; Tanner et al； 1991; Plane et al., 1992), oxidized LDL 
prepared with different oxidation method resulted in variation in inhibition of 
endothelium-dependent relaxation. Whereas some oxidized LDL preparations did not 
promote significant alterations in vascular reactivity, others were able to reduce 
markedly both maximal endothelium-dependent relaxation and the sensitivity to 
acetylcholine of arterial segments. As mentioned in Chapter 2, the oxidized LDL 
prepared in vitro by using copper(II) sulphate markedly reduced both maximal 
endothelium-dependent relaxation and the sensitivity to acetylcholine. In addition, it 
increased the maximum contraction force of the arterial segments. The present study 
was attempted to (1) connect the compositional changes of LDL after oxidation by 
copper(II) sulphate and the inhibition of endothelium-dependent relaxation, and (2) 
investigate contribution of each component in oxidized LDL to the effect. 
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The present study showed that LPC content was significantly increased in 
oxidized LDL when compared with that of native LDL. The present result was in 
agreement with that of Deckert et al (1997)，who also found that LPC was 
significantly increased in oxidized LDL. Previous studies showed that LPC in 
oxidized LDL was solely responsible for the inhibition of endothelium-dependent 
relaxation in rabbit aorta (Kugiyama et. al, 1990; Mangin et al., 1993; Yokoyama et. 
al, 1990). It was LPC itself could cause an inhibition on endothelium-dependent 
relaxation. The present study demonstrated that LPC might not represent the most 
important factor responsible for the inhibition of artery relaxation by oxidized LDL, 
as LPC only caused a small inhibition on the artery relaxation. The percentage 
inhibition on endothelium-dependent relaxation caused by LPC was 12.21 土 1.36%， 
while that of oxidized LDL was 61.22 土 10.12o/o. The discrepancy with previous 
studies may be due to difference in species and artery used. The present finding was 
supported by a previous study by Tanner et al. (1991)，who also found that LPC was 
not solely responsible for the inhibitory effect of oxidized LDL. 
The present study found oxidized LDL had a significant increase in COPs when 
compared to that of native LDL. The present result was in agreement with that of 
Bhadra et al. (1991) and Jialal et al (1991)，who found that COPs was significantly 
increased in oxidized LDL. COPs comprise a wide family of molecules that result not 
only from oxidation of LDL, but also from auto-oxidation of cholesterol in air or from 
enzymatic transformation of cholesterol in various cell species (Sevanian et al., 1985; 
/ 
Martin et al., 1973). In addition, COPs have been shown to be present in a number of 
foodstuffs, including dried egg products, powdered milk, and cheese, as well as in a 
variety of high-temperature dried animal products (Addis et al., 1980; Smith et al., 
1987). COPs have been reported to have a specific role in toxic effect of three major 
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cells types, including endothelial cell (Sevanian et al., 1991)，smooth muscle cell 
(Hennig et a!” 1987) and fibroblasts (Highley et al., 1987). The level of COPs has 
been found to be abnormally elevated in hypercholesterolemic plasma and 
atherosclerotic aortas from humans (Hodis et al., 1991; Carpenter et al” 1993). In the 
present study, 5 COPs were tested against artery relaxation, including 
5a-hydroxycholesterol, 7-ketocholesterol, 7a-hydroxycholesterol, 
7(3-hydroxycholsterol, 25-hydrocholesterol or the mixture of these 5 COPs. It was 
found that only COPs oxidized in position 7 including 7-ketocholesterol, 
7a-hydroxycholesterol and 7P-hydroxycholsterol, but not other cholesterol oxides 
were potent inhibitors of the endothelium relaxation of rat aorta. It was found that 
COPs mixture showed the greatest percentage inhibition on artery relaxation (23.76 土 
3.94%), while inhibition by 7-ketocholesterol, 7a-hydroxycholesterol and 
7|3-hydroxycholsterol was 8.53 土 2.20%, 7.33 土 2.53 % and 15.63 土 5.18%, 
respectively. The present result was in agreement with Deckert et al. (1997), who 
found that COPs in position 7 could partially inhibit the endothelium-dependent 
relaxation in rabbit aorta. However, both individual COPs and COPs mixture were not 
able to induce the inhibition of endothelium-dependent relaxation similar to that 
caused by oxidized LDL, suggesting that other oxidized components present in 
oxidized LDL be also responsible. 
The present study also examined the effect of oxidized linoelic acid (18:2) and 
the oxidized linolenic acids (18:3) on the endothelium-dependent relaxation. The 
oxidized fatty acids were usually found together with the COPs. It was found that 
oxidized linoleic acid caused a significant inhibition on endothelium-dependent 
relaxation but not the oxidized linolenic acid. The percentage inhibition caused by 
oxidized linoleic acid was 18.59 土 5.36o/o. This is the first study to demonstrate the 
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effect of oxidized fatty acids on endothelium-dependent relaxation in rat aorta. 
The present data demonstrated clearly that the inhibitory effect of oxidized 
LDL on aortic relaxation was not solely due to any specific component. In this regard, 
LPC, COPs and oxidized linolenic acid must exhibit synergistically their inhibition on 
the endothelium-dependent relaxation of aorta. 
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Chapter 5 
Effects of dietary oxidized cholesterol on blood 
cholesterol level in hamsters 
5.1 Introduction 
Cholesterol is susceptible to oxidation under various conditions. In contact 
with air, it is autoxidized, forming cholesterol hydroperoxides, from which >30 
secondary oxidation products, named cholesterol oxidation products (COPs), have 
been reported (Smith, 1992). Table 5.1 shows the list of some commonly found COPs. 
Foods containing cholesterol, particularly those that have been exposed to heat and air 
during processing or shelf life, could contain cholesterol oxidation products, such as 
dairy products (Angulo et al； 1997), fried and roast salmon (Echarte et al•’ 2001), and 
processed squids (Jeung et al., 1996) and marine foods (Osada et al., 1993). 
Generally, heat, pH, light, oxygen, water activity, and the presence of 
unsaturated fatty acids are the major factors that influence COP formation during food 
processing or storage. Although the formation pathways of certain COPs still have not 
been fully clarified (Tai et al., 1999)，it is known that the main COPs are formed 
during autoxidation in C7 (e.g. 7-ketocholesterol, 7a-hydroxycholesterol and 
7P-hydroxycholesterol) and C5-6 positions (e.g. 5a-hydroxcholesterol and a-epoxide) 
and in side chain (C20 and C25, e.g. 25-hydrocholesterol). Figure 5.1 shows the 
proposed scheme of cholesterol oxidation. Amount of COPs in foods can frequently 
reach 1% of total cholesterol and occasionally 10% or more (Kumar et al., 1992). In a 
review about the content of COP in foods (Tai et al., 2000), concluded that the most 
processed products containing cholesterol are susceptible to form COPs, with heating 
being the most common causative factor. 
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Table 5.1 
Nomenclature of common cholesterol oxidation products 
(Adapted from Francesc et al., 2002) 






19-hydroxycholesterol Cholest-5-en-3p, 19-diol 
20a-hydroxycholesterol Cholest-5-en-3p,20a-diol 
25-Hydroxycholesterol Cholest-5-en-3P,25-diol 





Cholesterol-3p,6a-diol Cholestan-3 P,6a-diol 
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Proposed scheme of cholesterol oxidation (Adapted from Osada et al” 1993) 
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COPs have received much scientific attention due to their undesirable 
implications in human health, such as disturbance of arachidonic acid metabolism 
(Seillan et al., 1990)，inhibition of cholesterol biosynthesis, alteration of membrane 
function, cytotoxicity, factoring in atherosclerosis (Smith et ah, 1989), carcinogenesis 
(Wrensch et al., 1989) and mutagenicity (Peterson et al., 1988) Humans are capable 
of absorbing cholesterol oxides from foods into the bloodstream (Emanuel et al” 
1991). Previous studies (Staprans et al., 1998) demonstrated that cholesterol oxidation 
products in the diet can accelerates fatty streak lesion formation in aortas of 
cholesterol-fed rabbits. In LDL receptor-deficient and apolipoprotein E 
(apo-E)-deificient mice, feeding of cholesterol oxidation products resulted in a 
significant increase in aortic fatty streak lesions (Staprans et al., 2000). There are 
some studies indicating that high intakes of cholesterol oxidation products from food 
can increase plasma COP levels (Emanuel et al., 1991). The American diets contain 
large quantities of oxidized cholesterol (Angulo et al., 1997) due to the fact that a 
large portion of the fat and cholesterol in the diet is often prepared in a fried, heated or 
processed form. Staprans et al. (1998) found that the cholesterol oxidation products 
obtained from the diet result in oxidized lipids in serum lipoproteins in human. 
Since American fast foods, such as McDonald's and Kenturkey Fried Chicken, 
are very popular in Hong Kong, they both provide deep fried foods. And the seafoods 
are also very popular in Hong Kong. The people in Hong Kong are at risk of taking in 
a large amount of cholesterol oxidation products from these foods. The present study 
was to determine the effect of cholesterol oxidation products on blood cholesterol 
level in male Golden Syrian hamsters, and to determine whether the COPs can cause 
much worst effect on health than cholesterol. 
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5.2 Objectives 
The objectives of present study was to investigate the effect of oxidized 
cholesterol on blood cholesterol level, atherosclerotic plaque formation and aortic 
relaxation ability in male Golden Syrian hamsters compared with non-oxidized 
cholesterol 
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5.3 Materials and Methods 
5.3.1 Preparation of Oxidized Cholesterol 
Pure Cholesterol (lOOg) was taken into a round bottom flask and kept in a 160�C 
oil bath and supplied with air for about 72 hours with continuous stirring. Figure 5.2 
shows the set up for making oxidized cholesterol. At the end of the treatment, the 
cholesterol showed a dark brown color with an obnoxious smell and was assigned to 
as oxidized cholesterol. The oxidized cholesterol was then subjected to GC analysis to 
check for amount of cholesterol oxidation products contained in the oxidized 
cholesterol. In brief, 20 mg of oxidized cholesterol was heated with 5 ml IN NaOH in 
90% ethanol at 90 °C for 1 hour. 6 mL of cyclohexane were added for extraction of 
cholesterol oxidation products. The cyclohexane phase was evaporated to dryness 
under nitrogen, and cholesterol was converted to its TMS-ether derivative by a 
commercial TMS-reagent (dry pyridine-hexamethyldisilazane- trichlorosilane, 9: 3: 1， 
v/v/v，Sil-A regent, Sigma). After 1 hour at 60 the mixture was dried by flushing 
with nitrogen. The TMS-ether derivative was dissolved in 500 |aL of hexane, and after 
centrifugation, the hexane phase was transferred to a vial for gas-liquid 
chromatograph (GLC) analysis. The TMS-ether derivative was analyzed in a fused 
silica capillary column (SAC™-5, 30 m x 0.25 mm, i.d.; Supelco, Inc., Bellefonte, PA, 
USA) in a Shimadzu GC-14B GLC equipped with a flame-ionization detector 
(Shimadzu). The column temperature was set at 285°C and maintained for 25 
minutes. Helium was used as carrier gas at a head pressure of 22 psi. 
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Figure 5.2 
(a) Detailed diagram shows the setup for making oxidized cholesterol, (b) Photo of 
setup described in (a), (c) Color of oxidized cholesterol (left) and pure cholesterol 
(right) 
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5.3.2 Diet preparation 
The control diet (CON) was prepared by mixing powdered ingredients in the 
following proportions: casein, 20%; lard, 10%; starch, 56.9%; sucrose, 5%; mineral 
mix, 4%; vitamin mix, 2% and DL-methionine, 0.1%. The remaining four diets were 
prepared by adding 0.05% pure cholesterol (C-0.05), 0.1% pure cholesterol (C-0.1), 
0.05% oxidized cholesterol (OxC-0.05) and 0.1% oxidized cholesterol (OxC-0.1) into 
the control diet. All powdered diets were then mixed with gelatin solution (20g/L) in a 
ratio of lOOOg diet per liter of solution. Once the gelatin had set, the diet was cut into 
approximately lOg cubic portions and stored at -20�C. Table 5.2 shows the 
composition of diets. 
5.3.3 Animals 
Fifty (100-120 g) male Golden Syrian hamsters were housed (2 hamsters per 
cage) in an animal room at 2 5 � C with 12:12-h light-dark cycle. All hamsters were 
free access to a stock diet (Glen Forrest Stockfeeds, Western Australia, Australia) for 
10 days. The hamsters were randomly divided into five groups with ten hamsters in 
each group and fed one of the five diets described above. They were allowed to freely 
access to diet. The amount of diet consumed was recorded daily and the body weight 
was recorded once a week. Feces were collected for a period of 7 days at the 2" ,^ 4出 
and 6th week. 
At the end of 6 weeks, all the hamsters were killed after overnight fasting. 
Blood was collected via the abdominal aorta. After clotting, the blood was 
centrifUged at 1500 g for 10 minutes and serum was collected. The liver and brain 
were removed, washed with saline, and stored at - 8 0 � C . The thoracic aortas were 




Composition of diets for the five groups of hamsters 
Percentage CON C-0,05 OxC-0.05 C-0,1 OxC-0.1 
Casein 20.00 20.00 20.00 20.00 20.00 
Lard 10.00 10.00 10.00 10.00 10.00 
Starch 56.90 56.85 56.85 56.80 56.80 
Sucrose 5.00 5.00 5.00 5.00 5.00 
Mineral mix 4.00 4.00 4.00 4.00 4.00 
Vitamin mix 2.00 2.00 2.00 2.00 2.00 
DL-methionine 0.10 0.1 0.10 0.10 0.10 
Cholesterol 0 0.05 0.04 0.10 0.08 
Ox-cholesterol 0 0 0.01 0 0.02 
Gelatin 2.00 2.00 2.00 2.00 2.00 
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5.3.4 Serum lipid and lipoprotein determinations 
Serum TG and TC levels were determined using enzymatic kits (Sigma Chemical, 
St. Louis, MO, USA). HDL-C was measured after precipitation of LDL and VLDL 
with phosphotungstic acid and magnesium chloride, using a commercial kit (Sigma). 
5.3.5 GC analysis of cholesterol and cholesterol oxidation products on organs 
Liver (300 mg), brain (300 mg), aorta (lOOmg) were used to determine the 
cholesterol level. In brief, organ and 1 mg stigmastanol (0.2 mg for aorta), as an 
internal standard, was extracted with 15 mL chloroform-methanol (2:1, v/v). The 
chloroform-methanol phase was removed and dried by flushing with nitrogen. After 
1 hour mild hydrolysis with 5 mL IN NaOH in 90% ethanol at 90 °C，1 mL of water 
and 6 mL of cyclohexane were added for extraction of cholesterol. The cyclohexane 
phase was evaporated to dryness under nitrogen, and cholesterol was converted to its 
TMS-ether derivative by a commercial TMS-reagent (dry pyridine-
hexamethyldisilazane-trichlorosilane, 9: 3: 1, v/v/v, Sil-A regent, Sigma). After 1 
hour at 60 °C, the mixture was dried by flushing with nitrogen. The TMS-ether 
derivative was dissolved in 500 |LIL of hexane, and after centrifiigation, the hexane 
phase was transferred to a vial for gas-liquid chromatograph (GLC) analysis. The 
TMS-ether derivative was analyzed in a fused silica capillary column (SAC™-5, 30 m 
X 0.25 mm, i.d.; Supelco, Inc., Bellefonte, PA, USA) in a Shimadzu GC-14B GLC 
equipped with a flame-ionization detector (Shimadzu). The column temperature was 
set at 285°C and maintained for 25 minutes. Helium was used as carrier gas at a 
head pressure of 22 psi. 
5.3.6 Extraction of neutral and acidic sterols from fecal samples 
The fecal neutral and acidic sterols were determined according to the method 
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described by Czubayko et al (1991) with some modifications. The fecal samples 
were first dried in a lyophilizer and then grounded into powder. Stigmasterol (0.5 
mg in 1 mL of chloroform) was added into a tube as an internal standard for total 
neutral sterols. The tube was dried down under a gentle stream of nitrogen. Then 
300 mg of grounded fecal sample and 0.5 mg hyodeoxycholic acid (0.5 mg in 2 mL 1 
N NaOH) as an internal standard for total acidic sterols were added. The samples 
were then subjected to alkaline hydrolysis with 8 mL 1 N NaOH in 90% ethanol at 90 
�C for 1 hour followed by cooling down to room temperature. Then 1 mL of 
distilled water and 8 mL of cyclohexane were added to extract total neutral sterols. 
After centrifugation, the upper cyclohexane phase and the lower aqueous phase were 
separated, and the total neutral and acidic sterols were quantified as described below. 
5.3.6.1 Determination of neutral sterols 
The cyclohexane phase was evaporated to dryness under a gently stream of 
nitrogen. The neutral sterols were converted to their TMS-ether derivatives using 
TMS-reagent (dry pyridine-hexamethyldisilazane-trichlorosilane, 9: 3: 1, v/v/v, Sil-A 
regent, Sigma) at 6 0 � C for 1 hour. The mixture was then dried down under 
nitrogen stream and the TMS-derivatives of neutral sterols were dissolved in 400 |LIL 
of hexane. After centrifugation, the hexane layer was transferred to a vial for GLC 
analysis. 
5.3.6.2 Determination of acidic sterols 
For determination of acidic sterols, 1 mL of 10 N NaOH was added to the lower 
aqueous phase. The mixture was heated for 3 hours at 1 2 0 � C . Distilled water (3 
mL) was added to the mixture and cooled at room temperature. The mixture was 
acidified with 1 mL of 25% HCl. And the acidic sterols were extracted with 7 mL 
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diethyl ether for two times. The ether phases were pooled and then dried down 
under a stream of nitrogen. Methylation of the acidic sterols was performed by 
adding 2 mL of methanol, 2 mL of dimethoxypropane and 40 \iL of concentrated HCl. 
The mixture was mixed thoroughly and allowed to stand at room temperature for 
overnight. The solvents were then dried down under a stream of nitrogen. 
TMS-reagent was added and heated at 6 0 � C for one hour to convert the acidic 
sterols into their TMS-ether derivatives. The mixture was dried down under a 
stream of nitrogen and the TMS-derivatives were dissolved in 300 |LIL of hexane. 
After centrifugation, the hexane layer was transferred to a vial for GLC analysis. 
5.3.63 GLC analysis of neutral and acidic sterols 
The analysis of fecal neutral and acidic sterols was carried out in a GLC 
equipped with a fused silica capillary column (SAC™-5, 30 m x 0.25 mm, i.d.; 
Supelco, Inc., Bellefonte, PA, USA) in a Shimadzu GC-14B GLC equipped with a 
flame-ionization detector (Shimadzu). For the neutral sterols, the column temperature 
was set at 285 °C and maintained for 30 min. For the acidic sterols, the column 
temperature was programmed from 2 3 0 � C to 2 8 0 � C at a rate of 1 � C / min. 
Helium was used as a carrier gas at a head pressure of 22 psi in both neutral and 
acidic sterol analysis. Typical chromatograms of neutral and acidic sterols were 
shown in Figures 5.3 and 5.4, respectively. 
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Figure 5.3 
Gas liquid chromatogram of neutral sterols in feces. Identification of peaks: 1， 
coprostanol; 2，coprostanone; 3’ cholesterol; 4，dihydrocholesterol; 5， 





10. 1 4 
f i ：I 
I j h I: 6 
f | 1 I i I 
0 � 
1 1  
0 20 40 
m i n 
Figure 5.4 
Gas liquid chromatogram of acidic sterols in feces. Identification of peaks: 1， 
lithocholic acid; 2，deoxycholic acid; 3, chenodeoxcholic acid; 4，cholic acid; 5, 
hyodeoxycholic acid (internal standard) and 6，ursodecholic acid. 
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5.3.7 Organ bath experiment 
5.5.7.1 Preparation of aorta 
The thoracic aorta was dissected out as described elsewhere in Chapter 2.3.4, 
and surrounding connective tissues and fat were removed under dissection microscope. 
Then, one part of the aorta was cut into 3 mm long aortic ring segements and each 
segment was suspended between two stainless steel hooks in a 10 ml organ bath 
chamber filled with normal Krebs-Henseleit solution (119 mM NaCl, 4,7 mM KCl, 
2.5 mM CaCl2，1 mM MgCli, 25 mM NaHCOs, 1.5 mM KH2PO4, 11.1 mM 
D-glucose). The chamber was bubbled with a mixture of 95% oxygen and 5 % carbon 
dioxide and kept at 37�C throughout the experiment. For the two stainless steel hooks, 
one of them was mounted at the bottom of the bath while another one was connected 
to a Grass FT03 force-displacement transducers (Grass Instrument) and the isometric 
contraction was measured by transducer and recorded by MacLab computer system 
(Fig 2.2). One-gram basal tension was applied to all aortic rings and rings were 
allowed to equilibrate for 30 minutes. During this time, the bath solution was replaced 
with pre-warmed, oxygenated Krebs-Henseleit solution for 3 to 4 times. After 
equilibrate period, the rings were first contracted with 0.3|iM phenylephrine to test 
vessel's contractibility and then relaxed by 0.3|iM acetylcholine to assess integrity of 
the endothelial layer. Then, the rings were rinsed several times in pre-warmed and 
oxygenated Krebs-Henseleit solution until the baseal tension was restored and allow 
to equilibrate for 60 mins. 
5.5.7.2 Aortic relaxation 
In order to examine the effect of feeding pure and oxidized cholesterol diet on 
acetylcholine-induced relaxation after the contraction and relaxation ability of aortic 
rings were tested, it was allowed to restore its basal tension for 60 mins. Then the 
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concentration-response curve on acetylcholine was constructed by adding l^M 
phenylephrine and waited until its maximal contraction, then followed by addition of 
3nM to 10|xM acetylcholine to produce a concentration-response relaxation curve to 
acetylcholine. 
5.3.8 Analysis of the total area of atherosclerotic plaque on aorta 
The percentage area of atherosclerotic plaque on endothelial layer was 
determined. In brief, the remaining part of thoracic aorta was cut opened vertically. 
The aorta was then stained with 0.5g Sudan III in 10 ml ethanol for 3 hours. The 
endothelial layer of aorta was then washed with distilled water for 3 times and 
scanned with a table scanner (Epson 1220 perfection, Epson Co., Japan). The area of 
atherosclerotic plaque was measured with the aid of computer images analyzing 
program "Sigma Scan Pro 5.0" (SPSS, Inc., Chicago, USA). 
5.3.9 Statistics 
Organ bath results were expressed as percentage relaxation of the 
agonist-constricted arterial rings. Data was presented as means 土 SD of (n=6) 
experiments. And other data was presented as means 土 SD of (n=6) experiments. 
Statistical significance was analyzed by Student's t-test or by one way ANOVA 
followed by Newman-Keuls test when more than two treatments were compared. 
Statistical difference was considered significant when p<0.05. 
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5.4 Results 
5.4.1 GC of oxidized cholesterol 
The GC analysis of the oxidized cholesterol sample revealed that 22.3% of 
cholesterol was converted to COPs. The COPs contained 1.8% 5a-hydroxycholesterol, 
4.6% Ta-hydroxycholesterol, 8.3% 7(3-hydroxycholesterol, 4.9% 7-ketocholesterol 
and 2.8% a-epoxide. GC graph of oxidized cholesterol was shown in Figure 5.5. 
5.4.2 Growth and food intake 
The body weight gain and food intake of hamsters are shown in Table 5.6. No 
significant differences in body weight, fluid intake and food intake were observed 
among the CON, C-0.05, C-0.1, OxC-0.05 and OxC-0.1 groups. 
5.4.3 Effect of non-oxidized and oxidized cholesterol on serum TC, TG and 
HDL-C 
Significant increase in serum TC was observed in the C-0.05, C-0.1, OxC-0.05 
and OxC-0.1 when compared with the value of the CON group (P<0.01). Serum TC 
of OxC-0.1 was the highest and significantly higher than that of OxC-0.05, C-0.1 and 
C-0.05 (Table 5.7). To be specific, the serum TC in the C-0.05, C-0.1, OxC-0.05 and 
OxC-0.1 groups were 23.4%, 51.3%, 50.5% and 68.3% higher than that in the CON 
group, respectively. OxC-0.05 and OxC-0.1 groups had serum TC significantly 
higher than the corresponding non-oxidized cholesterol group. 
For the serum TG, the C-0.05, C-0.1，OxC-0.05 and OxC-0.1 groups were 
significant higher than that of CON group. Serum TG of OxC-0.1 was the highest and 
significantly higher than that of OxC-0.05, C-0.1 and C-0.05. The serum TG in the 
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Figure 5.5 
Gas liquid chromatogram of COPs in oxidized cholesterol. 
Identification of peaks: 1，5a-hydroxycholesterol； 2，7a-hydroxycholesterol; 3， 
7p-hydroxycholesterol; 4’ Cholesterol; 5，7-ketocholesterol; 6，a-epoxide. 
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higher than that in the CON group, respectively (Table 5.7). The groups fed diets 
containing oxidized cholesterol had serum TG level significantly higher than their 
corresponding group fed diets containing non-oxidized cholesterol. 
For Serum HDL-C, C-0.1, OxC-0.05 and OxC-0.1 groups were significant 
higher than that of CON and C-0.05 groups. HDL-C level of Ox-C groups was again 
the highest and significantly higher than that of corresponding non-oxidized 
cholesterol groups. (Table 5.7) 
5.4.4 Effect of non-oxidized and oxidized cholesterol on non-HDL-C and ratio of 
non-HDL-C to HDL-C 
Non-HDL-C levels for the CON, C-0.05, C-0.1, OxC-0.05 and OxC-0.1 were 
51.8 士 6.2，74.6 士 13.3，92.7 士 10.1, 93.5 土 11.6 and 104.9 土 11.6 mg/ dL, respectively. 
A significant increase in non-HDL-C by 44.0%, 79.0%, 80.5% and 102.5% when 
compared with that in the CON group was observed in the C-0.05, C-0.1, OxC-0.05 
and OxC-0.1 groups respectively (Table 5.7). The groups on oxidized cholesterol diets 
had non-HDL-C level significantly higher than their corresponding group on 
non-oxidized cholesterol diets. The ratios of non-HDL-C to HDL-C in the C-0.05, 
c-0.1，OxC-0.05 and OxC-0.1 groups were all found to be significantly higher than 
that of the CON group, but no differences was observed between the oxidized and 














































































































































































































































































































































































































































































































































5.4.5 Effect of non-oxidized and oxidized cholesterol on concentration of hepatic 
cholesterol 
The livers were weighted immediately after the hamsters were scarified. The 
hepatic cholesterol concentration in C-0.05, C-0.1, OxC-0.05 and OxC-0.1 were 
significantly higher than that of CON group. The hepatic cholesterol in the CON, 
C-0.05, c-0.1, OxC-0.05 and OxC-0.1 was 6.21 士 2.09，16.9 土 3.99, 44.6 土 5.6, 18.3 土 
5.8 and 23.5 ± 5 . 1 mg/ g of liver, respectively (Figure 5.8). OxC-0.1 group had 
hepatic cholesterol concentration significantly higher than that of C-0.1 group. 
5.4.6 Effect of non-oxidized and oxidized cholesterol on concentration of 
cholesterol oxidation products accumulated in liver 
The concentration of COPs was found to be significantly higher in C-0.05, C-0.1, 
OxC-0.05 and OxC-0.1 groups when compared to that of CON group. The 
concentration of COPs detected in CON is only 0.09 土 0.03 mg/g of liver, while liver 
COP concentration in C-0.05, C-0.1, OxC-0.05 and OxC-0.1 groups were 460 times, 
261 times, 1442 times and 1409 times higher than that of CON group (Table 5.9). The 
groups on oxidized cholesterol diets had COP concentration significantly higher than 
their corresponding group on non-oxidized cholesterol diet. 
5.4.7 Effect of non-oxidized and oxidized cholesterol on concentration of brain 
and aortic cholesterol 
There was no significant difference in brain cholesterol content among the five 
groups (Figure 5.10). The aortic cholesterol concentration in C-0.05, C-0.1, OxC-0.05 
and OxC-0.1 were significantly higher than that of CON group. The aortic cholesterol 
in the CON, C-0.05, c-0.1, OxC-0.05 and OxC-0.1 was 0.46 土 0.12, 1.35 土 0.10，1.51 
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土 0.12，1.59 士 0.13 and 1.79 士 0.15 mg/ g of aorta, respectively (Figure 5.10). The 
group fed on oxidized cholesterol diets had aortic cholesterol concentration 
significantly higher than their corresponding group on non-oxidized cholesterol diet. 
5.4.8 Effect of non-oxidized and oxidized cholesterol on fecal neutral and acidic 
sterols 
The neutral sterols refer to a sum of coprostanol, coprostanone, cholesterol, 
dihydrocholesterol, campersterol, and (3-sitosterol. The total fecal neutral sterols 
were significantly elevated in the C-0.05, C-0.1, OxC-0.05 and OxC-0.1 groups when 
compared with that in the CON group (p<0.01). This result was due to the 
significant increase in the coprastanol (in all 4 groups, p<0.05), coprostanone (all 4 
groups, p<0.05), cholesterol (all 4 groups, p<0.01), dihydrocholesterol (in OxC-0.05 
and OxC，0.1 groups, p<0.05) and campersterol (in OxC-0.05 and OxC-0.1 groups, 
p<0.05) (Table 5.11). For (3-sitosterol, no significant difference was observed among 
the five groups. There was no significant difference between the oxidized groups and 
their corresponding non-oxidized groups in total fecal neutral sterols. 
The acidic sterols measured include lithocholic, deoxycholic, cholic and 
ursodeoxycholic acid. The total fecal acidic sterols were significantly elevated in the 
C-0.05, C-0.1, OxC-0.05 and OxC-0.1 groups when compared with that in the CON 
group (p<0.01) (Table 5.12). This result was due to the significant increase in the 
lithocholic acid (in OxC-0.05 and OxC-0.1 groups, p<0.05), deoxycholic acid (in 
C-0.1 and OxC-0.1 groups, p<0.05), cholic acid (in all 4 groups, p<0.05) when 
compared to that of CON groups (Table 5.12). No significant difference in total 
fecal acidic sterol was observed between oxidized groups and their corresponding 
non-oxidized groups. 
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Figure 5.8 
Effects of pure cholesterol (C-0.05, C-0.1) and oxidized cholesterol (OxC-0.05, 
OxC-0.1) on the hepatic cholesterol concentration of hamsters. Data are 
expressed as means 士 S.D. (n=10). Means with different letters (a, b, c, d) 
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Figure 5.10 
Effects of pure cholesterol (C-0.05，C-0.1) and oxidized cholesterol (OxC-0.05’ 
OxC-0.1) on the brain and aortic cholesterol concentration of hamsters. Data 
are expressed as means 士 S.D. (n=10). Means with different letters (a, b, c, d) 
























































































































































































































































































































































































































































































































































































































































































5.4.9 Effect of non-oxidized and oxidized cholesterol on aortic relaxation 
In order to examine the effect of feeding non-oxidized and oxidized 
cholesterol diet on acetylcholine-induced relaxation, After the contraction and 
relaxation ability of aortic rings were tested, it was allowed to restore its basal tension 
for 60 mins. Then the concentration-response curve on acetylcholine was constructed. 
There was significant inhibition on C-0.05, C-0.1, OxC-0.05 and OxC-0.01 groups 
when compared with that of the CON group, while OxC-0.01 caused the greatest 
inhibition on acetylcholine-induced relaxation (Figure 5.13A). The maximal 
relaxation shown by CON, C-0.05, C-0.1, OxC-0.05 and OxC-0.1 were 42.3 士 6.7， 
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Figure 5.13 
Concentration-response curves for 1|JM phenylephrine hydrochloride-induced 
contractile responses and 3nM - 10|JM acetylcholine-induced concentration 
-dependent relaxation in hamster's aortic rings. (A) Effect of pure cholesterol 
(C-0.05, C-0.1) and oxidized cholesterol (OxC-0.05, OxC-0.1) feeding on 
acetylcholine-induced concentration- depentdent relaxation. (B) The maximal 
relaxation (Emax %) induced by acetylcholine. Data are expressed as means 土 
SEM (n=10). Mean with different letters (a, b, c) differ significantly at P<0.05. 
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5.4.10 Effect of non-oxidzied and oxidized cholesterol on area of atherosclerotic 
plaque 
The percentage area of atherosclerotic plaque located on the endothelium of 
thoracic aorta was determined with the aid of Sigma Scan Pro 5.0. Significant increase 
in the total area of atherosclerotic plaque was observed in OxC-0.1 group when 
compared with that of CON group. All the other groups, C-0.05, C-0.1, OxC-0.05 
showed no significant increase in the total area of atherosclerotic plaque when 
compared with that of CON group (Figure 5.14). 
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Figure 5.14 
Percentage area of atherosclerotic plaque on the endothelium of pure 
cholesterol (C-0.05, C-0.1) and oxidized cholesterol (OxC-0.05, OxC-0.1)-fed 
hamsters. Data are expressed as means 土 S.D (n=10). Mean with different 
letters (a, b) differ significantly at P<0.05. 
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5.5 Discussion 
High cholesterol intake was one of the contributing factors to cardiovascular 
disease. In addition, COPs have also received much scientific attention due to their 
undesirable implications in human health. Earlier investigators demonstrated that 
oxidized lipid stimulated lipid peroxidation in animal and human tissue (Kubow, 
1993). 
The objective of the present study was to investigate whether the COPs could 
cause much worst effect on health than non-oxidized cholesterol. The present study 
used the oxidized cholesterol diet to simulate deep fried foods. It was found that both 
non-oxidized cholesterol and oxidized cholesterol increased serum TC and TG levels, 
but the latter was more potent in hamsters. There was also an increase in non-HDL-C 
level in hamster fed both the non-oxidized and oxidized cholesterol diets compared 
with the control diet. However, oxidized cholesterol was more effective in elevating 
non-HDL-C level than non-oxidized cholesterol diet, suggesting that not only high 
cholesterol diet but also oxidized cholesterol in diet be a risk factor leading to 
cardiovascular disease. Previous studies by Kanhal et al. (2002) also found that 
oxidized cholesterol was more potent in raising the serum TC level in rats, but 
non-oxidized cholesterol was more potent in increasing serum TG level. The 
discrepancy may be due to different species and different amount of oxidized/ 
non-oxidized cholesterol used in the diets. 
The present study also demonstrated that oxidized cholesterol caused a higher 
accumulation of COPs than non-oxidized cholesterol in liver, suggesting that 
consuming oxidized cholesterol be more dangerous than non-oxidized cholesterol. 
However, 0.1% non-oxidized cholesterol caused a higher accumulation of cholesterol 
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than 0.1% oxidized cholesterol in liver, and both oxidized cholesterol and 
non-oxidized did not affect the brain cholesterol level. The mechanism that 
non-oxidized cholesterol was more potent than oxidized cholesterol in accumulation 
of cholesterol in liver remained unexplored. One possible mechanism suggested by 
Osada et al. (1995) that oxidized cholesterol may reduce HMG-CoA reductase 
activity and reduced liver cholesterol level. It was also supported by Erickson et al. 
(1977) and Saucier et al. (1993)，that they suggested that various oxygenated 
derivatives of cholesterol, such as 7-ketocholesterol and 25-hydroxychoelsterol have 
been reported to lower HMG-CoA reductase activity after short-term feeding. The 
results obtained from the present study agreed with Osada et al. (1995), but did not 
agreed with Kanhal et al. (2002)，who found that non-oxidized and oxidized 
cholesterol were equally potent in increasing the cholesterol level in rat liver. The 
discrepancy may be again due to different species and different amount of oxidized/ 
non-oxidized cholesterol used in the diets. 
The absorption rates of cholesterol were similar basis on observation that fecal 
content of cholesterol in both non-oxidized and oxidized cholesterol-fed groups were 
similar. The major metabolites of cholesterol are bile acids. Greater excretion of bile 
acids was observed in both non-oxidized and oxidized cholesterol-fed groups when 
compared to the control. The levels of fecal bile acids were similar in both 
non-oxidized and oxidized cholesterol-fed groups, suggesting that oxidized 
cholesterol did not affect bile excretion and cholesterol metabolism in hamsters. This 
is the first report to demonstrate oxidized cholesterol did not affect bile acids 
excretion when compared to non-oxidized cholesterol. 
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The present study also showed that oxidized cholesterol significantly increased 
atherosclerotic plaques in hamster's aorta when compared to that of non-oxidized 
cholesterol. This can be explained by the increased cholesterol level in aorta. The 
result is in agreement with that reported by Mahfouz et al. (1997), who also found that 
oxidized cholesterol was more potent in stimulating the formation of atherosclerotic 
plaque than non-oxidized cholesterol. The present study found that both non-oxidized 
and oxidized cholesterol significantly inhibited acetylcholine-induced relaxation. 
However, non-oxidized cholesterol caused only a small inhibition, while 0.1% 
oxidized cholesterol caused a great inhibition, suggesting oxidized cholesterol in diets 
could cause strong endothelial damages. This is the first report to demonstrate 
endothelial damage by dietary oxidized cholesterol. The reason that oxidized 
cholesterol significantly increased aortic plaque and cholesterol, and inhibited 
endothelium-dependent relaxation was still unknown. Stapran et al. (1998 and 2003) 
suggested that dietary cholesterol could incorporate into lipoprotein once it was 
absorbed, causing the formation of oxidized LDL and atherogenesis. One of the 
possible mechanisms for the present results was that dietary oxidized cholesterol 
incorporated into lipoprotein and lead to the formation of oxidized LDL, which then 
accumulated on the endothelium to form atherosclerotic plaque, and at the same time, 
oxidized LDL could impair endothelium-dependent vasorelaxation as shown in 
Chapter 2. 
In this study, it was not very efficient to produce oxidized cholesterol, even 
by heating it at 160�C oil bath and supplied with air up to 72 hours with continuous 
stirring. Only about 20% of COPs was produced. Osada et al suggested that 
cholesterol alone was very stable and resist to oxidation by heating. When cholesterol 
was heated with saturated fats like tristearin and beef tallow, only a little COP was 
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produced after long-term heating since saturated fatty acids is stable and is not readily 
oxidized. The degree of saturation seems to be a factor affecting the rate of COPs 
produced. However, there is no study suggest that heating cholesterol with 




Oxidized LDL is believed to be an active culprit in cardiovascular diseases. 
Oxidized LDL is involved in the development of atherosclerotic plaques. People with 
cardiovascular diseases usually have high levels of LDL and oxidized LDL. The value 
of circulating oxidized LDL can be used to predict the cardiovascular risk. 
The present study demonstrated the inhibitory effect of oxidized LDL on 
endothelium-dependent relaxation by acetylcholine in vitro. It was found that 
short-term exposure to oxidized LDL inhibited the relaxation and the effect of 
inhibition was directly proportional to time and dose of oxidized LDL incubated. On 
the other hand, co-incubation of native LDL and copper(II) sulphate also inhibited 
endothelium-dependent relaxation by acetylcholine, due to the oxidation of native 
LDL by copper(II) sulphate. Interestingly, oxidized LDL only targeted on the 
endothelium, but not on the smooth muscle cells. It was found that oxidized LDL did 
not affect the eNOS protein expression level. L-arginine treatment did not recover the 
inhibition, while SNP treatment only partially reversed the effect. Treatment of 
a-tocopherol up to lOOjxM could only partially reduced the inhibition effect of 
oxidized LDL, while a-tocopherol caused a better improvement if the effect was 
caused by co-incubation of native LDL and copper(II) sulphate. It was concluded that 
a-tocopherol could reduce the impairment of endothelium due to its antioxidant 
activity to prevent oxidation of LDL, but a-tocopherol did not provide a strong 
protection on endothelium once the oxidized LDL was formed. 
The in vivo test on effect of oxidized LDL on endothelium-dependent 
relaxation demostrated that oxidized LDL not only affected the 
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endothelium-dependent relaxation by acetylcholine, but also interrupted the 
cholesterol balance in rats. Oxidized LDL significantly increased TC, non-HDL and 
non-HDL to HDL ratio, which significantly increased the risk of cardiovascular 
diseases. Besides, oxidized LDL also increased the aorta's contractile response to 
phenylephrine hydrochloride, meaning that the basal NO release was partly impaired. 
The analysis of LDL composition revealed that oxidized LDL contained less 
unsaturated fatty acids (e.g. oleic acid, linoelic acid, linolenic acid, arachidonic acid) 
than native LDL while saturated fatty acids were the same. Large amount of COPs 
was detected in oxidized LDL with la- and 7p- hydroxycholesterol being the most 
abundant. High level of LPC was also detected in oxidized LDL. Interestingly, a small 
amount of COPs and LPC were detected in native LDL. Since native LDL did not 
caused any inhibition on endothelium-dependent relaxation, low level of COPs and 
LPC in native LDL should not caused any inhibition on the endothelium. The present 
study demonstrated that LPC and COPs (same concentrations as in oxidized LDL) 
affected the endothelium-dependent relaxation by acetylcholine. It was found that 
LPC, COPs at 7-position and oxidized linoleic acid caused a small but significant 
inhibition on endothelium-dependent relaxation. No single compound could induce 
the same inhibition effect as exhibited by oxidized LDL as a whole. It is concluded 
that the LPC, COPs and oxidized fatty acids may acts synergistically to cause such a 
great inhibition on endothelium-dependent relaxation. 
The effect of dietary oxidized cholesterol on blood cholesterol level was tested 
in hamsters. Dietary oxidized cholesterol and non-oxidized cholesterol at level of 
0.1% could significantly increased serum TC, TG, HDL, non-HDL and non-HDL to 
HDL ratio in hamsters with the former being more potent than the latter. Oxidized 
cholesterol also increased aortic cholesterol level and atherosclerotic plaque area, and 
inhibited endothelium-dependent relaxation by acetylcholine, suggesting that dietary 
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oxidized cholesterol be a risk factor leading to cardiovascular diseases. Both oxidized 
and non-oxidized cholesterol significant caused the accumulation of cholesterol in the 
liver. However, oxidized cholesterol diet accumulated a greater amount of cholesterol 
oxidation products in the liver. The present study suggests that not only a high 
cholesterol diet but also a high oxidized cholesterol should be avoided and further 
investigations in humans are required to determine whether dietary oxidized 
cholesterol caused the same effects in human as that observed in hamster. 
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